MERCK
MRKNext catalyst
IDVYNSO
HIV-1 infection in certain virologically suppressed adults
Get an email about MRK's next catalysts
Track MERCK (MRK) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 60 more upcoming events in our data (Phase 2 readout, Phase 3 readout, PDUFA date).See the timeline
64 upcoming, 9 past
Axatilimab Phase 2 Est. Readout
Estimated primary completion for Axatilimab trial (NCT05491226) in TNBC - Triple-Negative Breast Cancer. Topline data typically follows completion by weeks to months.
SourcePembrolizumab Phase 2 Est. Readout
Estimated primary completion for Pembrolizumab trial (NCT04421560) in Primary Central Nervous System Lymphoma. Topline data typically follows completion by weeks to months.
Sourcepembrolizumab Phase 2 Est. Readout
Estimated primary completion for pembrolizumab trial (NCT04879329) in Urothelial Carcinoma. Topline data typically follows completion by weeks to months.
SourceTU2218 + KEYTRUDA® (Pembrolizumab) Phase 2 Est. Readout
Estimated primary completion for TU2218 + KEYTRUDA® (Pembrolizumab) trial (NCT05784688) in Solid Tumor. Topline data typically follows completion by weeks to months.
Zero cancer recurrence in 32 patients after nearly three years of follow-up with neoadjuvant pembrolizumab before surgery
SourceInfliximab Phase 2 Est. Readout (RAPID-I)
Estimated primary completion for Infliximab trial (NCT03684278) in Acute Pancreatitis. Topline data typically follows completion by weeks to months.
SourcePembrolizumab Phase 2 Est. Readout
Estimated primary completion for Pembrolizumab trial (NCT05756569) in Bladder Squamous Cell Carcinoma. Topline data typically follows completion by weeks to months.
SourceBelzutifan Phase 2 Est. Readout
Estimated primary completion for Belzutifan trial (NCT05468697) in Renal Cell Carcinoma. Topline data typically follows completion by weeks to months.
SourceLenvatinib Phase 2 Est. Readout
Estimated primary completion for Lenvatinib trial (NCT05147558) in Uterine Carcinosarcoma. Topline data typically follows completion by weeks to months.
SourceUpcoming FDA decisions
How MRK's past catalysts played out
Market Overview
Stock performance and key metrics
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
WebsiteKEYTRUDA®
Cervical Cancer
ANV600 + pembrolizumab (KEYTRUDA®)
Advanced Solid Tumor
TU2218 + KEYTRUDA® (Pembrolizumab)
Solid Tumor
Glipizide
Diabetes Mellitus, Type 2
Cladribine Low Dose
Generalized Myasthenia Gravis
Colistimethate sodium (CMS)
Bacterial Infections
Acarbose
Type 2 Diabetes Mellitus
Rebif® New Formulation (IFN-beta-1a, RNF)
Multiple Sclerosis, Relapsing-Remitting
Patritumab Deruxtecan
Malignant Neoplasm
M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX®
Measles
regorafenib
Colorectal Cancer
Fluorouracil (5-FU)
Urinary Bladder Neoplasms
Elbasvir/Grazoprevir Fixed Dose Combination
Chronic HCV Infection
Rizatriptan co-administered with Acetaminophen
Migraine
Peginterferon alfa-2b (PEG)
Hepatitis C, Chronic
sitagliptin phosphate (+) metformin hydrochloride
Type 2 Diabetes Mellitus
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine
HPV Infections
2XP HEPTAVAX™-II SC
Hepatitis B
Ribavirin (SCH 18908)
Hepatitis C, Chronic
V110, pneumococcal vaccine polyvalent
Healthy
montelukast sodium
Asthma
R-DXD
Lung Neoplasm
Rocuronium bromide (Zemuron)
Anesthesia
Gardasil
Papillomavirus Infections
Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine
Cervical Cancer
ART
HIV-1 Infection
Pegylated interferon alfa-2b (PegIntron)
Hepatitis B, Chronic (CHB)
Sitagliptin plus metformin
Type 2 Diabetes Mellitus
DOR
HIV-1 Infection
M-M-R®II
Pneumococcal Infections
Linezolid
Pneumonia
liposomal doxorubicin
Breast Neoplasms
diquafosol tetrasodium (INS365) ophthalmic solution
Dry Eye Disease
denufosol tetrasodium (INS37217) Inhalation Solution
Cystic Fibrosis
succinylcholine
Neuromuscular Blockade
Intismeran
Non-small Cell Lung Cancer
MK-1084
Colon Adenocarcinoma
AzaSite
Bacterial Conjunctivitis
rosiglitazone
Type 2 Diabetes Mellitus
Cyclophosphamide
Metastatic Breast Cancer
VARIVAX™ New Seed Process
Varicella
peg-IFN
Hepatitis C, Chronic
Sofosbuvir
Hepatitis C
Pneumococcal Vaccine, Polyvalent (23-valent)
Pneumococcal Infection
Reformulated Raltegravir
HIV Infection
Ribavirin (RBV)
Hepatitis C, Chronic
simvastatin/ezetimibe
Hyperlipidemia
Cetrorelix acetate
Polycystic Ovarian Syndrome
REBETOL (ribavirin; SCH 18908)
Hepatitis C, Chronic
Background PAH Therapy
Pulmonary Arterial Hypertension
RotaTeq™ - Rotavirus Vaccine, Live, Oral, Pentavalent
Vomiting
levoleucovorin
Esophageal Squamous Cell Carcinoma (ESCC)
losartan potassium + hydrochlorothiazide + amlodipine besylate (MK-0954E)
Hypertension
V503 Vaccine
Papillomavirus Infections
boceprevir (SCH 503034)
Chronic Hepatitis C
V110
Pneumococcal Infection
Tivantinib
Advanced Solid Tumors
Cetuximab plus Platinum-based Doublet Chemotherapy
Non-Small Cell Lung Cancer (NSCLC)
Saizen® A
Children Born With Serious Intra-uterine Growth Retardation
vinflunine
Urothelial Cancer
MK-0524B
Primary Hypercholesterolemia
Sevoflurane
Muscle Relaxation
LdT (Telbivudine) and lamivudine
Hepatitis B
BIC/FTC/TAF
HIV-1 Infection
lovastatin
Atherosclerosis
L-PZQ ODT
Schistosomiasis
daptomycin
Pneumonia, Bacterial
Tenofovir + lamivudine + raltegravir
HIV-1 Infection
MK-8748
Diabetic Retinopathy
HIBERIX™
Pneumococcal Infections
MMRV (AMP)
Measles
Folinic Acid
Metastatic Colorectal Cancer
Lamivudine
HIV Infections
RotaTeq™ experimental formulation
Rotavirus Gastroenteritis
Modified Process Hepatitis B Vaccine
Hepatitis B
Ifinatamab Deruxtecan
Castration-Resistant Prostatic Cancer
MK0557
Obesity
Bomedemstat
Thrombocythemia, Essential
Sulfonylurea
Type 2 Diabetes Mellitus
Pembrolizumab (MK-3475)
Merkel Cell Carcinoma
Zidovudine
HIV Infections
MK-0518
HIV Infections
alvimopan
Ileus
Kuvan®
Phenylketonuria
Tulisokibart
Hidradenitis Suppurativa
luspatercept
B-Thalassemia
Pioglitazone hydrochloride
Type 2 Diabetes Mellitus
BCG
Urinary Bladder Neoplasms
Rebif®
Clinically Isolated Syndrome
Zoster Vaccine, Live (Oka-Merck)
Varicella Virus Infection
Nemtabrutinib
Chronic Lymphocytic Leukemia
Grazoprevir/Elbasvir fixed-dose combination
Chronic Hepatitis C
Zoster Vaccine, Live (Oka-Merck), ZOSTAVAX™
Herpes Zoster
Prevnar 13®
Streptococcus Pneumoniae Infection
Pembrolizumab Formulated with Berahyaluronidase Alfa
Metastatic Non-small Cell Lung Cancer
Extended-release niacin (ERN)
Dyslipidemia
Prevnar 13™
Pneumococcal Infections
Pneumovax™ 23
Pneumococcal Infections
MK0831
HIV Infections
RotaTeq (V260)
Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9
Preservative-Free Tafluprost
Open-angle Glaucoma
Palivizumab
RSV Infection
Posaconazole
Mycoses
Rotateq™
Rotavirus Infections
Clesrovimab
Respiratory Syncytial Viruses
ProQuad (Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live)
Measles
Metformin - Rescue
Diabetes Mellitus, Type 2
Filgrastim
Metastatic Non-small Cell Lung Cancer
Infanrix® hexa
Varicella
granisetron
Chemotherapy-induced Nausea and Vomiting (CINV)
MK-8527
Human Immunodeficiency Virus (HIV)
PCV15 - Part B
Pneumococcal Disease
Zoster Vaccine, Live (Zostavax™)
Shingles
Zilovertamab vedotin
B-cell Acute Lymphoblastic Leukemia
Doravirine, Tenofovir, Lamivudine
HIV-1 Infection
Pembrolizumab/Quavonlimab
Colorectal Cancer
MK-5172A
Chronic Hepatitis C
PegIntron (peginterferon alfa-2b; SCH 54031)
Hepatitis
Grazoprevir
Chronic Hepatitis C (CHC)
IV Tulisokibart
Crohn's Disease
PEG-Intron
Hepatitis C
Granulocyte Colony-Stimulating Factor (G-CSF)
DLBCL
MK0217, alendronate sodium
Osteoporosis
DOR/ISL
HIV Infection
Emtricitabine/tenofovir disoproxil (FTC/TDF)
Human Immunodeficiency Virus (HIV)
Zoster Vaccine, Live
Herpes Zoster
Efprezimod alfa
Graft Versus Host Disease
Zoster Vaccine, Live (AMP)
Herpes Zoster
Gonalef® (Follitropin alfa)
Infertility
Cisplatin/Carboplatin
Carcinoma, Squamous Cell of Head and Neck
Rocuronium bromide (Org 9426)
Muscle Relaxation
Naproxen
Endometriosis-related Pain
ProQuad® manufactured with recombinant Human Albumin (rHA)
Measles
Gardasil™
Papillomavirus Infections
Varicella Virus Vaccine Live (Oka-Merck)
Varicella
Fosaprepitant dimeglumine
Chemotherapy-Induced Nausea and Vomiting (CINV)
V181
Healthy
Human Papillomavirus (HPV) 16 Monovalent
Cervical Cancer
PegIntron
Hepatitis C
Atropine
Anesthesia, General
Glycemic Rescue 1
Diabetes Mellitus
RECOMBIVAX HB™
Pneumococcal Infections
Sitagliptin + Pioglitazone
Type 2 Diabetes Mellitus
Axitinib
Renal Cell Carcinoma
fidaxomicin
Clostridium Difficile-Associated Diarrhea (CDAD)
Rocuronium intubating
Anesthesia
Androgen Deprivation Therapy (ADT)
Metastatic Hormone-Sensitive Prostate Cancer
Rocuronium bolus maintenance
Anesthesia
Glimerpiride
Type 2 Diabetes Mellitus
losartan potassium
Hypertension
anacetrapib
Coronary Heart Disease (CHD)
MK0524A
Flushing
V114
Pneumococcal Infections
Cisplatin (as radiosensitizer)
Endometrial Neoplasms
Vecuronium
Anesthesia, General
Suvorexant Low Dose (LD)
Primary Insomnia
Peginterferon alfa-2b (PEG2b)
Hepatitis C, Chronic
sitagliptin phosphate
Type 2 Diabetes
Peg-interferon alfa-2b
Hepatitis C, Chronic
dorzolamide hydrochloride (+) timolol maleate
Glaucoma
peg-Interferon alfa-2a
Hepatitis C, Chronic
Calderasib
Non-small Cell Lung Cancer
ZOSTAVAX
Herpes Zoster
Relebactam
Intra-abdominal Infections
Infliximab
Psoriasis
(Gardasil™) human papillomavirus (types 6, 11, 16, 18) recombinant vaccine
Condylomata Acuminata
rofecoxib
Prostate Cancer
Peginterferon
Multiple Myeloma
M-M-R II™
Varicella
Oral Switch
Suspected or Documented Gram-negative Bacterial Infection
H2 Receptor Antagonist
Non-small Cell Lung Cancer (NSCLC)
RotaTeq®
Meningitis, Meningococcal
ProQuad®
Measles
MK0991, caspofungin acetate/Duration of Treatment
Fungal Infection
Sitagliptin/simvastatin FDC
Type 2 Diabetes Mellitus
Pre-treatment with rLH (Luveris)
Infertility, Female
Cilastatin
Bacterial Pneumonia
Pegylated filgrastim
Metastatic Non-small Cell Lung Cancer
IV golimumab
Arthritis, Rheumatoid
RotaTeq™, rotavirus vaccine, live, oral, pentavalent
Rotavirus Infections
Quadrivalent Human Papillomavirus (HPV, Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®)
Papillomavirus Infections
Boceprevir (BOC)
Chronic Hepatitis C
Intismeran autogene
Bladder Cancer
MK0869, aprepitant
Postoperative Nausea and Vomiting
Infliximab + methotrexate (IFX + MTX)
Arthritis, Psoriatic
Rebif New Formulation + prophylactic Ibuprofen
Relapsing Multiple Sclerosis
Metformin IR
Type 2 Diabetes Mellitus
Pembrolizumab/Vibostolimab Co-Formulation
Small Cell Lung Carcinoma
Voriconazole
Aspergillosis
Short ragweed pollen allergen extract
Rhinitis, Allergic, Seasonal
MK0803, lovastatin
Hypercholesterolemia
Aprepitant
Post-operative Nausea
MK-3475A
Non-small Cell Lung Cancer
PPSV23
Pneumococcal Disease
Trifluridine-Tipiracil
Gastroesophageal Cancer
Rescue medication
Non-Muscle Invasive Bladder Cancer
Tisotumab Vedotin
Cervical Cancer
Pembrolizumab (K)
Breast Cancer
Zoster Vaccine Live
Herpes Zoster
niacin (+) laropiprant
Hypercholesterolemia
TAS-102 (trifluridine and tipiracil)
Colorectal Neoplasms
favezelimab/pembrolizumab
Hodgkin Lymphoma
Golimumab
Spondylitis, Ankylosing
zoster vaccine live (ZOSTAVAX™)
Herpes Zoster
Diquafosol tetrasodium ophthalmic
Dry Eye Disease
Granulocyte colony stimulating factor: Filgrastim or Pegfilgrastim
Triple Negative Breast Neoplasms
TAS-102
Colorectal Cancer
Infliximab + methotrexate (MTX)
Arthritis, Rheumatoid
Montelukast
Asthma
Boceprevir
Chronic Hepatitis C Genotype 1
Ensifentrine
COPD
Epirubicin
Triple Negative Breast Neoplasms
Enlicitide
Hyperlipidemia
Esmirtazapine
Insomnia
Pergoveris®
Infertility
Meropenem
Healthcare-Associated Pneumonia
ER niacin/laropiprant
Diabetes Mellitus Type 2
PNEUMOVAX™23
Pneumococcal Infections
Enalapril
Hypertension
Tedizolid phosphate
Acute Bacterial Skin and Skin Structure Infections
r-hCG
Infertility
Ceftolozane/Tazobactam
Complicated Intra-Abdominal Infection
hMG
Infertility
Cetuximab + Platinum (Cisplatin or Carboplatin) + 5Fluorouracil (5-FU)
Head and Neck Cancer
Grazoprevir + Elbasvir
Hepatitis C Infection
Cetuximab + concomitant boost radiotherapy
Squamous Cell Carcinoma of the Head and Neck
SC golimumab
Arthritis, Rheumatoid
Voglibose
Diabetes Mellitus, Non-Insulin-Dependent
ER-niacin
Primary Hypercholesterolaemia
MK-1293
Type 1 Diabetes Mellitus
Bisoprolol/Amlodipine (Bisoprolol failed group)
Hypertension
PAR-101/OPT-80
Clostridium Infections
ZOSTAVAX™
Herpes Zoster
cetuximab + cisplatin + vinorelbine
Non Small Cell Lung Cancer (NSCLC)
Ertapenem sodium
Infection; Diabetic Foot
sitagliptin/metformin ≥
Type 2 Diabetes Mellitus (T2DM)
ER niacin (+) laropiprant (ERN/LRPT)
Dyslipidemia
MK0966
Pain, Postoperative Arthroscopy
MK0966; Rofecoxib
Colorectal Adenoma
Decadron
Malignant Neoplasms of Male Genital Organs
L50/H12.5/A5
Hypertension
Frespaciguat
Pulmonary Hypertension
MK0826
Complicated Intra-Abdominal Infections
sugammadex
Neuromuscular Blockade
pneumococcal 23v polysaccharide vaccine
Pneumococcal Infection
niacin (+) laropiprant (+) simvastatin
Primary Hypercholesterolemia
Modified Process Hepatitis B Vaccine (Experimental)
Hepatitis B
Pembrolizumab/Vibostolimab
Lung Neoplasms
Tedizolid Phophate
Skin Diseases, Infectious
MK0507A, dorzolamide hydrochloride (+) timolol maleate
Glaucoma
Finasteride
Enlarged Prostate
raltegravir
HIV
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL™)
Papillomavirus Infections
V212
Herpes Zoster
raltegravir potassium
HIV Infections
rotavirus vaccine, live, oral, pentavalent
Rotavirus Infections
Combination of pegylated interferon alfa-2b and ribavirin
Hepatitis C, Chronic
Dexamethasone
Non-Small-Cell Lung Carcinoma
Measles, Mumps, and Rubella Virus Vaccine Live (MMR)
Varicella
Grazoprevir/Elbasvir
Hepatitis C
MK0217A, alendronate sodium (+) cholecalciferol
Osteoporosis
hydrochlorothiazide (HCTZ)
Hypertension
pembrolizumab
Colorectal Neoplasms
Open-label Metformin
Type 2 Diabetes
loratadine; montelukast
Rhinitis, Allergic, Seasonal
Recombinant Human Papillomavirus Nonavalent Vaccine
AIDS-Related Human Papillomavirus Infection
caspofungin acetate
Fungal Infection
Isentress®
HIV Infections
Acid Nicotinique
Acute Coronary Syndrome (ACS)
laropiprant/niacin (MK0524A)
Hypercholesterolemia
Sitagliptin
Hyperlipidemia
9vHPV vaccine
Papillomavirus Infections
2XP HEPTAVAX™-II IM
Hepatitis B
Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live
Measles
Olaparib
Ovarian Cancer
Mitomycin C (MMC)
Urinary Bladder Neoplasms
Lantus™
Type 2 Diabetes Mellitus
Gonal-f®
Assisted Reproductive Techniques
IPV
Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9
FTC/TDF + EFV or LPV/R +T20
HIV Infections
Human Chorionic Gonadotropin (hCG)
Luteal Hormone Supplementation in In-vitro Fertilization
Ropeginterferon alfa-2b
Polycythemia Vera
7-valent pneumococcal-CRM197 conjugate vaccine
Otitis Media
COL-1620
Luteal Hormone Supplementation in In-vitro Fertilization
V441, diptheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant), & Haemophilus influenza type b conjugate vaccine
Diphtheria
Stavudine
HIV Infections
Glycemic Rescue
Type 2 Diabetes Mellitus
Raptiva
Moderate to Severe Psoriasis
M-M-R II®
Varicella
mRNA-1273 Vaccine
Papillomavirus Infections
V501
Human
Rescue Medications
Cervical Cancer
MTX
Arthritis, Rheumatoid
Vancomycin (or equivalent)
Acute Hematogenous Osteomyelitis
Insulin
Type 2 Diabetes Mellitus
Ezetimibe
Hypercholesterolemia
Preladenant
Parkinson Disease
Calcium supplement
Osteoporosis
oral contraceptive pill pretreatment (Marvelon)
Infertility, Female
V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine
Cervical Cancer
V920 Consistency Lot A
Prevention of Ebola Infection
Peginterferon alfa-2a
Hepatitis C, Chronic
sitagliptin/metformin
Type 2 Diabetes Mellitus
Letermovir
Cytomegalovirus Infection
Opevesostat
Prostate Cancer Metastatic
Sotatercept
Pulmonary Arterial Hypertension
Bezlotoxumab
Clostridium Difficile Infection
V232 Modified Process Hepatitis B Vaccine: Lot A
Hepatitis B Infection
Riociguat (Adempas, BAY63-2521)
Hypertension, Pulmonary
PCV20
Pneumococcal Infection
PCV13
Pneumococcal Infections
Pentacel™
Pneumococcal Infections
losartan potassium (+) hydrochlorothiazide
Hypertension
V260
Rotavirus Gastroenteritis
Varicella Virus Vaccine Live (2007 Process) (Oka/Merck)
Varicella
Prednisone
Prostate Cancer Aggressiveness
Ezetimibe/Simvastatin
Type 1 Diabetes Mellitus
ISL/ULO
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Ertugliflozin
Type 2 Diabetes Mellitus
Interferon-alpha2b - 1 year
Melanoma
Varicella-zoster vaccine
Herpes Zoster
Cladribine (MAVENCLAD®)
Advanced Multiple Sclerosis
Tobramycin
Bacterial Conjunctivitis
Pegylated interferon alfa-2b
Hepatitis C
Peginterferon alfa-2b
Carcinoma, Hepatocellular
Ipragliflozin
Type 2 Diabetes Mellitus
Rocuronium bromide
Anesthesia
IMI/REL
Suspected or Documented Gram-negative Bacterial Infection
MK0966, rofecoxib
Postoperative Pain
Basal Insulin
Type 2 Diabetes Mellitus
Posaconazole oral suspension
Mycoses
sac-TMT
Non-small Cell Lung Cancer
Grazoprevir/Elbasvir FDC tablet (MK-5172A)
Chronic Hepatitis C
Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin
Hepatitis C, Chronic
Org 50081
Insomnia
budesonide and montelukast
Obstructive Sleep Apnea
Avonex®
Multiple Sclerosis, Relapsing-Remitting
Corifollitropin Alfa
Infertility, Female
Follitropin alfa liquid formulation
Infertility
Metronidazole
Complicated Intra-abdominal Infections
Ritonavir
HIV Infections
Vericiguat tablet
Heart Failure
Micronised Progesterone
Infertility
HBVAXPRO™
Hepatitis B
Paclitaxel
Non-small Cell Lung Cancer
VARIVAX™
Varicella
Levocarnitine
HIV Infections
SC Tulisokibart
Ulcerative Colitis
Imipenem+Cilastatin/Relebactam
Complicated Intra-abdominal Infection
Etoricoxib
Knee Osteoarthritis
MK0826, ertapenem sodium
Infections
Elbasvir
Hepatitis C
Vericiguat
Heart Failure
Doravirine
HIV-1
DAPTACEL™
Bacterial Infections
Telcagepant
Migraine
Pembrolizumab (+) Berahyaluronidase alfa
Lung Cancer
Fidaxomicin tablets
Clostridium Difficile-associated Diarrhea (CDAD)
IMI/REL FDC
Hospital-Acquired Bacterial Pneumonia
MMR II™
Pneumococcal Infections
Zanzalintinib
Renal Cell Carcinoma
Gardasill 9™ vaccine
Neoplasia
MK0974
Migraine
sitagliptin/pioglitazone q.d
Type 2 Diabetes Mellitus
Lenvatinib
Non-small Cell Lung Cancer
raltegravir (Isentress)
HIV Infections
week 24
Peripheral Spondyloarthritis
Fludrocortisone acetate
Prostate Cancer Metastatic
V503 (9-valent Human Papillomavirus L1 Virus-Like Particle vaccine)
Human Papillomavirus Infection
V116
Pneumococcal Infection
Omarigliptin
Type 2 Diabetes Mellitus
Vicriviroc
HIV Infections
Molnupiravir
Coronavirus Disease (COVID-19)
MR Prednisone
Rheumatoid Arthritis
ertapenem sodium (MK0826)
Urinary Tract Infection
Pegylated liposomal doxorubicin (SCH 200746)
Breast Cancer
VAQTA™
Pneumococcal Infections
peginterferon alfa-2b (SCH 54031)
Chronic Hepatitis C
Pembrolizumab SC
Non-Small Cell Lung Cancer
9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
HPV Positive Oropharyngeal Squamous Cell Carcinoma
ISL
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
MK-6072
Clostridium Difficile Infection
TR-701 FA
Skin and Subcutaneous Tissue Bacterial Infections
sodium chloride (NaCl)
Anesthesia
Combination of (a) pegylated interferon alfa-2b and (b) rebetol
Liver Transplantation
Pegylated interferon alfa-2b (SCH 54031)
Hepatitis C, Chronic
Neostigmine
Anesthesia
5-Fluorouracil
Uterine Cervical Neoplasms
CB-183,315
Clostridium Difficile Infection
INFANRIX™ hexa
Bacterial Infections
PR5I
Neisseria Meningitidis
Gefapixant
Chronic Cough
Gliclazide
Type 2 Diabetes Mellitus
ceftriaxone sodium
Infection
PCV15
Pneumonia, Pneumococcal
TRUVADA®
HIV Infections
eribulin
Metastatic Triple Negative Breast Cancer
Indinavir sulfate
HIV Infections
Delstrigo
HIV-1-infection
ezetimibe with simvastatin
Hypercholesterolemia
Ridaforolimus
Sarcoma
V503
Papillomavirus Infections
MK-0524A
Hypercholesteremia
Saizen®
Fibromyalgia
Supportive care measures
Non-small Cell Lung Cancer (NSCLC)
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live
Measles
Recombinant human luteinizing hormone (r-hLH)
Hypogonadism
mFOLFOX6
Colorectal Carcinoma
alendronate with cholecalciferol
Osteoporosis
Sitagliptin (MK0431)
Diabetes Mellitus, Type II
Ezetimibe + Atorvastatin
Hypercholesterolemia
Efavirenz
HIV Infections
V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine/Duration of Treatment: 4 years
Cervical Cancer
Peginterferon alfa-2b (PegIntron, SCH 54031)
Hepatitis D, Chronic
RNF
Multiple Sclerosis
ezetimibe (plus simvastatin)
Atherosclerosis
H1 receptor antagonist
Ovarian Cancer
Telcagepant potassium
Migraine
Epacadostat
Gastric Adenocarcinoma
Cisplatin
Head and Neck Neoplasms
Hepatitis A Vaccine, Purified Inactivated (VAQTA™)
Hepatitis A Virus Infection
Enlicitide Decanoate
Hypercholesterolemia
Odanacatib
Osteoporosis Postmenopausal
pegylated interferon alpha-2b
Hepatitis B, Chronic
Rotavirus vaccine
Bacterial Infections
MK-8591A
HIV-1 Infection
Estrogens
Infertility
Interferon-beta-1a
Hepatitis C
Dinaciclib
Chronic Lymphocytic Leukemia (CLL)
Acetaminophen (or equivalent)
Non-small Cell Lung Cancer (NSCLC)
V419
Bacterial Infections
Suvorexant
Insomnia
Dexamethasone (or equivalent)
Non-small Cell Lung Cancer (NSCLC)
ATRIPLA™
Human Immunodeficiency Virus (HIV)
MK-1045
Lymphoma, Non-Hodgkin
Rocuronium maintenance
Anesthesia
Rocuronium
Anesthesia, General
vaniprevir
Hepatitis C, Chronic
Blinatumomab
B-cell Acute Lymphoblastic Leukemia
Anagrelide
Essential Thrombocythemia
Steroid Mouthwash (dexamethasone or equivalent)
Non-small Cell Lung Cancer (NSCLC)
ULO
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
ZOSTAVAX™ (concomitant)
Herpes Zoster
Enpatoran
Systemic Lupus Erythematosus (SLE)
CXA-201
Complicated Urinary Tract Infection
Telcagepant soft
Migraine
VARIVAX® PE34 Process
Varicella
Rotarix™
Pneumococcal Infections
Vorinostat
Mesothelioma
Vericiguat suspension
Heart Failure
KOCITAF
HIV-1-infection
M-M-R™ II
Pneumococcal Infections
MK-3415
Clostridium Difficile Infection
Belzutifan
Renal Cell Carcinoma
Clonidine
Malignant Neoplasms of Male Genital Organs
Lisinopril
Kidney, Polycystic
Leucovorin/levoleucovorin
Metastatic Colorectal Cancer
Rocurium
Anesthesia, General
Surotomycin
Clostridium Difficile Infection
neostigmine and glycopyrrolate or atropine
Neuromuscular Blockade
rolofylline
Heart Failure, Congestive
Epinephrine
Malignant Neoplasms of Male Genital Organs
epinastine nasal spray, low concentration, low dose volume
Seasonal Allergic Rhinitis
Simvastatin
Cardiovascular Disease
INS365 Ophthalmic Solution
Keratoconjunctivitis Sicca
QIV
Pneumonia, Pneumococcal
Letermovir tablet
Cytomegalovirus Infection
peginterferon alfa-2b (PEG2b) (SCH 54031)
Hepatitis C, Chronic
Prulifloxacin
Acute Gastroenteritis in Adult Travelers
Acetaminophen/Paracetamol
Migraine Disorders
clindamycin/ketoconazole vaginal ovule
Vaginosis, Bacterial
Prevenar 13™
Pneumococcal Infections
Efalizumab
Moderate to Severe Psoriasis
Suvorexant High Dose (HD)
Primary Insomnia
Alviompan
Bowel Dysfunction
FOLFIRI (5-Fluorouracil, Folinic acid, Irinotecan)
Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer
Valganciclovir
CMV Disease
taranabant
Smoking
MK-7625A (ceftolozane/tazobactam)
Intra-abdominal Infection
Uridine 5'-Triphosphate (UTP) Solution for Inhalation
Lung Cancer
Imipenem
Bacterial Pneumonia
S-1
Gastric Cancer
Glycopyrrolate
Surgical Procedures, Elective
Rotavirus Vaccine, Live, Oral, Pentavalent (V260, RotaTeq™)
Rotavirus
Vaxelis™
Pneumococcal Infections
V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live
Measles
V501, Gardasil, Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine/Duration of Treatment : 4 Years
Cervical Cancer
RSV-A Memphis 37b
Respiratory Syncytial Viruses
Lonafarnib
Breast Cancer
Pemetrexed Cisplatin
Non Small Cell Lung Cancer
EVX-01
Melanoma Stage IV
PembroRT
Non-small Cell Lung Cancer, NSCLC
Brexucabtagene autoleucel (other names: brexu-cel, Tecartus)
Recurrent Mantle Cell Lymphoma
MK1903
Dyslipidemia
MK-2206
PANCREAS
Peginterferon alfa-2a (Peg-IFN)
Hepatitis C, Chronic
ANV600
Advanced Solid Tumor
Pembrolizumab/Favezelimab
Colorectal Cancer
Pembrolizumab (for 30 minutes
Breast Cancer
Ritonavir-boosted protease inhibitor
HIV
Uprifosbuvir (+) Grazoprevir (+) Ruzasvir
Hepatitis C
denufosol tetrasodium Inhalation Solution
Cystic Fibrosis
CXA-101
Complicated Urinary Tract Infection
pegylated interferon
Chronic Hepatitis C
Multiple low dose cyclophosphamide
Multiple Myeloma
Azacitadine
Acute Myeloid Leukemia
Cisplatin (TP)
Squamous Cell Carcinoma of the Hypopharynx
pIL-12
Melanoma
LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER
Solid Tumor, Adult
LY3537982
Carcinoma, Non-Small-Cell Lung
Butantan - DV
Dengue
KVA12123 Plus Pembrolizumab - Dose Escalation
Cancer
KVA12123 Plus Pembrolizumab - Dose Expansion
Cancer
denufosol tetrasodium (INS37217)
Cystic Fibrosis
OPT-80
Diarrhea
Dalotuzumab
Carcinoma, Non-small-cell Lung
MK-8777
Depression
KVA12123 - Dose Expansion
Cancer
ARQ 197
Pancreatic Neoplasms
ARQ 501
Cancer
ADL5945
Opioid Induced Constipation
Robatumumab
Colorectal Cancer
MK0431, sitagliptin phosphate
Diabetes Mellitus, Type II
M5717
Acute Malaria
MK0812
Arthritis, Rheumatoid
Vibostolimab
Melanoma
MK0493
Obesity
Selumetinib capsule formulation
Neurofibromatosis Type 1
INS37217 Nasal Spray
Perennial Allergic Rhinitis
MK0777
Generalized Anxiety Disorder
Uprifosbuvir
Hepatitis C
Pneumococcal Conjugate Vaccine (V114)
Pneumococcal Infections
V114 Aluminum-adjuvanted
Pneumococcal Infections
Vibostolimab/Pembrolizumab
Carcinoma, Renal Cell
MK-3120
Urothelial Carcinoma
Navarixin
Solid Tumors
Daptomycin for Injection
Bacteremia
UFOX + Cetuximab
Previously Untreated Metastatic Colorectal Cancer
Raludotatug Deruxtecan (R-DXd)
Gastrointestinal Cancer
Tepotinib
Non-small Cell Lung Cancer
TMC647055
Chronic Hepatitis C Virus
MK-3795
VHL Gene Mutation
V114 Lot 1
Pneumococcal Infections
adavosertib
Ovarian Cancer
MK0249
Attention-Deficit/Hyperactivity Disorder (ADHD)
MK-8435 (Org 25935)
Schizophrenia
MK-6096
Migraine
Pembrolizumab/vibostolimab coformulation
Bladder Cancer
irinotecan hydrochloride
Metastatic Colorectal Cancer
MK-0941
Type 2 Diabetes Mellitus
IDX719
Hepatitis C, Chronic
Ritonavir (RTV)
Chronic Hepatitis C Virus
MK2295
Pain, Postoperative
Quavonlimab
Advanced Solid Tumors
MK-1167
Alzheimer Disease
SCH 530348
Arterial Obstructive Diseases
Epinastine Nasal Spray
Seasonal Allergic Rhinitis
Merck L-830982
Schizophrenia
MK-4830
Carcinoma, Non-Small-Cell Lung
zoster vaccine live (Oka/Merck)
Shingles
Raludotatug Deruxtecan
Ovarian Cancer Recurrent
Coformulation favezelimab/pembrolizumab
Esophageal Squamous Cell Carcinoma (ESCC)
Fludrocortisone/Fludrocortisone acetate
Malignant Neoplasm
Fosaprepitant
Chemotherapy-induced Nausea and Vomiting
Farnesyl Protein Transferase Inhibitor
Leukemia
ADL5859
Peripheral Neuropathy
MK2461
Neoplasm
MK0991, caspofungin acetate
Aspergillosis
SCH 486757
Cough
Tecemotide (L-BLP25)
Lung Neoplasms
measles, mumps, and rubella virus vaccine live
Measles
AS900672-Enriched 50 microgram (mcg)
Infertility
Dexamethasone/Dexamethasone acetate
Malignant Neoplasm
Cilengitide
Carcinoma, Non-Small-Cell Lung
ecallantide
Bloodloss
Pembrolizumab (neoadjuvant)
Lung Neoplasm Malignant
MK0518
HIV Infections
Megestrol acetate/Medroxyprogesterone acetate
Malignant Neoplasm
ENB003
Cancer
MK-5684
Malignant Neoplasm
Attenuvax
HIV Infections
M5049 low dose
Systemic Lupus Erythematosus
Pegylated Interferon Alfa
Chronic Hepatitis C
KW-3902IV
Heart Failure, Congestive
Favezelimab
Advanced Non-Small Cell Lung Cancer
tildrakizumab
Psoriasis
SCH 900538
Seasonal Allergic Rhinitis
EBR/GZR FDC Tablet
HCV Infection
Mavyret
End Stage Renal Disease
MK0916
Diabetes Mellitus, Type 2
V160
Cytomegalovirus (CMV) Infections
MK-2140 (zilovertamab vedotin)
Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Cabazitaxel
Prostatic Neoplasms, Castration-Resistant
L-dopa
Parkinson Disease
MK0364
Obesity
Single low dose cyclophosphamide
Carcinoma, Non-Small-Cell Lung
MK-8189
Schizophrenia, Acute Episode
Recombinant human growth hormone (r-hGH)
Hypochondroplasia
CyPep-1
Advanced Head and Neck Squamous Cell Carcinoma
Pembrolizumab and Lenvatinib
Hepatocellular Carcinoma
Boserolimab
Small Cell Lung Cancer
2 NRTIs
Human Immunodeficiency Virus (HIV) Infection
PegIFN-2b
HIV Infections
PegIntron (peginterferon alfa-2b)
Hepatitis C, Chronic
Atorvastatin/niacin extended-release
Carotid Atherosclerosis
Rebif
Multiple Sclerosis
MK-0873
Rheumatoid Arthritis
Matuzumab
Esophageal Cancer
V504
Cervical Cancer
imipenem/cilastatin
Urinary Tract Infections
cetuximab, cisplatin
Breast Neoplasm
Interferon beta-1a
Alzheimer's Disease
V114 Medium Dose
Pneumococcal Infections
V181 High-Potency Level
Dengue Disease
cyclophosphamide (CPA)
Rectal Cancer
Biltricide (racemate praziquantel) oral tablets
Schistosomiasis
Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF)
Infertility Implantation Failure
SCH 900636
Depressive Disorders
Pegylated Lyposomal Doxorubicin
Breast Neoplasm
EMD 525797
Metastatic Colorectal Cancer
MK0782
Stomach Ulcer
TR701 FA
Major Cutaneous Abscess
Doravirine, Tenofovir, Lamivudine - Blinded
HIV-1
V940
Squamous Non-small Cell Lung Cancer
Efinopegdutide
Metabolic Dysfunction-Associated Steatotic Liver Disease
Cetuximab/avelumab
Head and Neck Squamous Cell Carcinoma (HNSCC)
PRA023 IV
Crohn Disease
Zolinza (vorinostat)
Lymphoma
Metolazone
Heart Failure
PegLiposomal Doxorubicin
Mesenchymal Tumor
ST-067
Cancer
Miransertib
PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)
MK-0893
Diabetes Mellitus, Type 2
GI-101A
Advanced Solid Tumor
ZA
Breast Cancer
L-756423
HIV Infections
timolol/dorzolamide combination
Glaucoma
AO-176
Solid Tumor
Esmeron®
Neuromuscular Blockade
NM283 plus Peg-IFNα-2a
Chronic Hepatitis C
MK-2060
End-Stage Renal Disease
IDX184
Chronic Hepatitis C Infection
Pleconaril
Asthma
KVA12123 - Dose Escalation
Cancer
Gocatamig
Small-Cell Lung Cancer
MK-1200
Advanced Solid Tumors
SCH 727965
Breast Neoplasms
V114-A
Pneumococcal Infections
IFN beta 1a TIW
Multiple Sclerosis
Pegylated Liposomal Doxorubicin
Breast Neoplasm
Lenvatinib Capsules
Hepatocellular Carcinoma
Avastin
High-grade Serous Ovarian Carcinoma
Atacicept
Rheumatoid Arthritis
Vibegron
Urinary Bladder, Overactive
Org 34517
Depression
MK-1029
Asthma
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate
HIV-1 Infection
TERN-701
Chronic Myeloid Leukemia, Chronic Phase
CRS-207
Metastatic Pancreatic Adenocarcinoma
Lenvatinib Oral Product
Merkel Cell Carcinoma
Coformulated favezelimab/pembrolizumab
Metastatic Urothelial Carcinoma
val-mCyd
Chronic Hepatitis C
Radium-223
Prostate Cancer
valopicitabine
Chronic Hepatitis C
MK0677
Alzheimer's Disease
Interferon-beta-1a, 44 microgram
Ulcerative Colitis
MK0991, caspofungin acetate/Duration of Treatment: variable
Candidiasis
Antihistamine
Esophageal Squamous Cell Carcinoma
Oral testosterone undecanoate (Andriol)
Hypogonadism
Dalantercept
Squamous Cell Carcinoma of the Head and Neck
Sugar Pill
Osteoarthritis of the Knee
Vorapaxar
Atherosclerosis
Docetetaxel
Carcinoma, Non-Small-Cell Lung
Pertuzumab
Breast Neoplasms
epinastine
Allergic Rhinitis
MK-8998
Schizophrenia
ATX-MS-1467
Multiple Sclerosis
Dalantercept plus sorafenib
Advanced Adult Hepatocellular Carcinoma
Nelfinavir mesylate
HIV Infections
AR51 (12, 10)
Bacterial Infections; Virus Diseases
EV
Bladder Cancer
diphenhydramine
Carcinoma, Non-Small-Cell Lung
MK-8616
Neuromuscular Blockade
Benznidazole
Chagas Disease
FF-10832
Advanced Urothelial Carcinoma
raltegravir and etravirine
HIV-1 Infection
MK8141
Hypertension
Elbasvir Oral Granules
HCV Infection
MK0822A
Vitamin D Deficiency
MK0633
Atherosclerosis
ATRIPLA^TM
HIV-1
NC318
Advanced Non-small Cell Lung Cancer
TATE and pembrolizumab
Colorectal Cancer; Lung Cancer
MK-2010
Advanced Solid Tumors
Interferon-beta-1a, 66 microgram
Ulcerative Colitis
Histamine H1 Receptor Antagonist
Advanced Solid Tumors
MK-3475 (pembrolizumab)
Ovarian Squamous Cell Carcinoma
Histamine H2 Receptor Antagonist
Advanced Solid Tumors
Grazoprevir Oral Granules
HCV Infection
Doravirine, Tenofovir, Lamivudine - Open-Label
HIV-1
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate -300 MG-300 MG
Hiv
suberoylanilide hydroxamic acid (SAHA, Vorinostat)
Breast Cancer
tamoxifen citrate (Tamoxifen)
Breast Cancer
MK633
Chronic Obstructive Pulmonary Disease (COPD)
Doxorubicin hydrochloride
Breast Neoplasms
INCB024360
Microsatellite-instability (MSI) High Colorectal Cancer (CRC)
r-FSH
Ovarian Stimulation
Enclitide Chloride
Hypercholesterolemia
Pimicotinib
Tenosynovial Giant Cell Tumor
Pembrolizumab/Olaparib
SCLC,Extensive Stage
Neoadjuvant Treatment - mFOLFOX6 & Pembrolizumab
Gastro Esophageal Junction Cancer
Pembrolizumab Injection
Squamous Cell Carcinoma
Interleukin-2
Kidney Cancer
coformulation pembrolizumab/quavonlimab
Small Cell Lung Carcinoma
ATRA
Melanoma
MK-2214
Early Alzheimer's Disease
Pembrolizumab & ADG106 (Phase Ib)
Advanced Solid Tumor
OBP-301
Esophageal Adenocarcinoma
Phase Ia dose-escalation part of FB849 Monotherapy
Advanced Solid Tumor
Dabrafenib
Melanoma
MK0524A, niacin (+) laropiprant
Flushing
ridaforolimus (MK8669)
Prostate Cancer
MK0683, vorinostat, Suberoylanilide Hydroxamic Acid (SAHA)
B-cell Lymphoma
Rolapitant Dose 1
Postoperative Nausea and Vomiting
MK0359
Pulmonary Disease, Chronic Obstructive
MK0524
Seasonal Allergies
peginterferon alfa 2b
Hepatitis C, Chronic
MK-7262
Lipoprotein(a)
DF9001
Solid Tumor, Adult
Sargramostim
Biliary Cancer
Taxol
Esophageal Adenocarcinoma
TS-1
Gastric Cancer
Rescue
Type II Diabetes Mellitus
AMG820 and pembrolizumab
Pancreatic Cancer
Recombinant human follicle stimulating hormone (r-hFSH)
Infertility
Regorafenib (Stivarga, BAY73-4506)
Hepatocellular Carcinoma
IRX 2
Breast Cancer
Itraconazole
Chronic Hepatitis C
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (V501)
HPV Infections
Pegylated Interferon (peg-IFN)
Hepatitis C
Vorinostat and Etoposide
Solid Tumors
Ifinatamab Deruxtecan (I-DXd)
Small Cell Lung Cancer
Ruzasvir
Hepatitis C
Letermovir oral granules
Cytomegalovirus (CMV) Infection
Raltegravir Film-coated Tablet
HIV Infection
teicoplanin
Osteomyelitis
SCH 900271
Primary Hypercholesterolemia
SCH 900518
Hepatitis C, Chronic
MK5757
Schizophrenia
Samatasvir
Chronic Hepatitis C Virus
Ulevostinag
Head and Neck Squamous Cell Carcinoma (HNSCC)
ARQ 501 in combination with gemcitabine
Pancreatic Cancer
V205C, measles, mumps, and rubella virus vaccine live
Measles
medroxyprogesterone acetate tablets OR megestrol acetate
Endometrial Cancer
Islatravir
HIV-1 Infection
RSV A Memphis 37b
Respiratory Syncytial Virus
SCH 619734
Cough
ADL5747
Osteoarthritis of the Knee
TR-701
Skin Diseases, Infectious
MK3207
Migraine
Grazoprevir (GZR)
Hepatitis C Virus
I-DXd
Esophageal Squamous Cell Carcinoma
SCH 56592
Onychomycosis
Grazoprevir/Elbasvir FDC
Hepatitis C
MK-5442
Osteoporosis
Caspofungin
Candidiasis, Esophageal
SCH 497079
Obesity
tretinoin
Acute Myeloid Leukemia
MK-0482
Carcinoma, Non-Small-Cell Lung
EBC
Colorectal Cancer
Guadecitabine
Recurrent Fallopian Tube Carcinoma
FLX475 (tivumecirnon)
Advanced Cancer
MK0736
Hypertension
FLX475
Gastric Cancer
Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 20/40/40/20
Papillomavirus Infections
MK0686
Pain, Postoperative
MK-6213
Hypercholesterolemia
VigantOL oil plus interferon beta-1a (Rebif)
Relapsing-Remitting Multiple Sclerosis
Vicriviroc maleate
HIV
MK-8690
Colitis Ulcerative
MK0429
Post-Menopausal Osteoporosis
Letermovir Pill
CMV
Pyronaridine
Malaria Infection
MK-0634
Urinary Incontinence
ridaforolimus + dalotuzumab
Breast Cancer
rolofyline
Congestive Heart Failure
Posaconazole IV
Invasive Aspergillosis
r-hFSH
Infertility
MK0639, indinavir sulfate
HIV Infections
PR51 (3, 10)
Bacterial Infections; Virus Diseases
carboplatin AUC of 6, paclitaxel, and pembrolizumab, i.v. on day 1
Squamous Cell Carcinoma of Larynx
Methotrexate 1 GM Injection
Gestational Trophoblastic Neoplasias (GTN)
TEW-7197
Metastatic Colorectal Cancer
M9140
Solid Tumors
Imprime PGG
Malignant Neoplasm of Breast
Mirdametinib
Central Nervous System Tumors
Crinone
Postmenopausal Endometrium
Posaconazole PFS
Invasive Fungal Infection
Bintrafusp Alfa
Nasopharyngeal Carcinoma
Pembrolizumab (Keytruda)
Thyroid Cancer
Axatilimab
TNBC - Triple-Negative Breast Cancer
Alendronate
Osteoporosis
Nirogacestat
Tumor
D-1553 in combination with Drug: pembrolizumab, Drug:KEYTRUDA®, Drug: cetuximab, Drug: other
Solid Tumor, Adult
Adjuvant Treatment - mFOLFOX & Pembrolizumab
Gastro Esophageal Junction Cancer
MK-3475 (adjuvant)
Cancer of Head and Neck
mRNA-4157
Melanoma
5-hydroxytryptamine 3 antagonist
Chemotherapy-induced Nausea and Vomiting
Boceprevir, Peg-interferon alfa 2b and Ribavirin
HCV Coinfection
Peg-Interferon α-2b or Peg-Interferon α-2a
HCV Infection
ATG-022
Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
ART Intensification
HIV-1 Infection
Allogeneic cytomegalovirus-specific T cells
Glioblastoma Multiforme
RPL554 Suspension
COPD
pembrolizumab KEYTRUDA®
Advanced Solid Tumor
MK-4208
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Carboplatin/Paclitaxel
Urologic Neoplasms
Bavituximab
Hepatocellular Carcinoma
Vorinostat, Lenalinomide and Dexamethasone
Multiple Myeloma
Talimogene Laherparepvec
Hepatocellular Carcinoma
STK-012
Advanced Solid Tumor
CPA
Relapsed Diffuse Large B-cell Lymphoma
Imipenem/Cilastatin/Relebactam
Hematopoietic and Lymphoid Cell Neoplasm
Posaconazole tablet
Invasive Aspergillosis
ISA101b
HPV-Related Squamous Cell Carcinoma
ADV/HSV-tk
Metastatic Non-small Cell Lung Cancer
Testosterone Enanthate
Male Hypogonadism
BET Bromodomain Inhibitor ZEN-3694
Castration-Resistant Prostate Carcinoma
olaparibp, embro
Ovarian Cancer
aprepitant, ondansetron, dexamethasone
Nausea
azacytidine
Lymphoma
galinpepimut-S
Acute Myelogenous Leukemia
Neoadjuvant Pembrolizumab
Breast Cancer
Entereg
Laparoscopic Colonic Resection
D-1553
Solid Tumor, Adult
Bilastine
Seasonal Allergic Rhinitis
Q901
Advanced Cancer
5HT3
Chemotherapy-Induced Nausea and Vomiting
FOLFIRI + Cetuximab
Metastatic Colorectal Cancer
GVAX Pancreatic Cancer Vaccine
Pancreatic Cancer
Lenvatinib Mesylate
Kidney Cancer
Polatuzumab vedotin
Lymphoma, Large B-Cell, Diffuse
IMGN853
Endometrial Cancer
GAd-209-FSP low dose
Solid Tumor, Adult
Peptide Receptor Radionuclide Therapy (PRRT) using 177Lu-DOTA0-Tyr3-Octreotate
Metastatic Malignant Neoplasm in the Liver
Vinblastine
Classical Hodgkin Lymphoma
Defactinib
Resectable Pancreatic Ductal Adenocarcinoma (PDAC)
ARX201
Growth Hormone Deficiency
Background ART Regimen
HIV Infections
r-hLH
Infertility
Obinutuzumab/Intravenous
Cancer
V114 High Dose
Pneumococcal Infections
V114 High Dose with Alternative Carrier Protein
Pneumococcal Infections
ACE-536
Beta-Thalassemia
Pembrolizuma
Metastatic Breast Cancer
Vorinostat Velcade Dexamethasone
Multiple Myeloma
Pembrolizumab with All-Trans Retinoic Acid
Stage IV Melanoma
Elpipodect
Schizophrenia
ABL103
Solid Tumors
CXA-101/tazobactam and metronidazole
Complicated Intra-abdominal Infection
modifiedFOLFOX6 + Cetuximab
Metastatic Colorectal Cancer
pembrolizumab, gemcitabine and cisplatin
Bladder Cancer
R-CHOP Protocol
B Cell Lymphoma
Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 40/40/40/40
Papillomavirus Infections
Pembrolizumab in
Metastatic Breast Cancer
IO102-103
Head and Neck Squamous Cell Carcinoma
Autologous dendritic cells
Follicular Lymphoma
Raltegravir Chewable Tablet
HIV Infection
darunavir/ritonavir
HIV Infections
V114 Lot 2
Pneumococcal Infections
M7824
Carcinoma, Non-Small-Cell Lung
Other Anti-Retroviral Therapy
HIV Infection
MK-3475 (neoadjuvant)
Cancer of Head and Neck
Bemcentinib
Lung Cancer Metastatic
Ulonivirine
HIV-1 Infection
Optimized background regimen
HIV Infections
indacaterol maleate/mometasone furoate
Asthma
etravirine
HIV Infections
open-label ridaforolimus (MK8669)
Prostate Cancer
PegIntron (PEG)
Chronic Hepatitis C
Atovaquone-Proguanil
Malaria Infection
Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 80/80/40/80
Papillomavirus Infections
Mocaciclib (Q901)
Advanced Cancer
V114 Medium Dose with Alternative Carrier Protein
Pneumococcal Infections
Poly-ICLC
Metastatic Colon Cancer
Pegylated Interferon alpha 2b
HIV-1 Infection
UFT
Metastatic Colorectal Cancer
Vinblastine Sulfate
Stage II Bladder Cancer AJCC v8
DPX-Survivac
Relapsed Diffuse Large B-cell Lymphoma
Bacillus Calmette-Guérin (BCG)
Bladder Cancer
HIF-2alpha Inhibitor PT2385
Recurrent Glioblastoma
pTVG-HP
Castration-resistant Prostate Cancer
emtricitabine/tenofovir disoproxil fumarate/raltegravir
HIV-2 Infection
L19TNF
Melanoma Stage III
GX-188E
Cervical Cancer
GSK2636771
Melanoma and Other Malignant Neoplasms of Skin
Human Papillomavirus vaccine
Cervical High Grade Squamous Intraepithelial Lesion
Tinodasertib
Metastatic Colorectal Cancer
Aprepitant/Ramosetron/Dexamethasone
Chemotherapy-Induced Nausea and Vomiting
Zepatier
End Stage Renal Disease
Prednisone or prednisolone
Metastatic Castration-resistant Prostate Cancer
Sitagliptin + Metformin
Pre-diabetes
ACP-196 in combination with pembrolizumab
Metastatic Urothelial Carcinoma
Cefepime
Other Infectious Diseases
Azithromycin ophthalmic
Blepharitis
129Xe Hyperpolarized
Pulmonary Hypertension
L19IL2
Melanoma Stage III
Pegzilarginase
Small-cell Lung Cancer
Spevatamig (PT886)
Gastric or Gastroesophageal Junction Adenocarcinoma
MK-1775 and carboplatin
Epithelial Ovarian Cancer
EIDD-2801
SARS-CoV 2
Pembrolizumab/Intravenous
Metastatic Uveal Melanoma
Gemox, Cetuximab
Advanced Biliary Cancer
Encorafenib Oral Capsule + Cetuximab
Colorectal Cancer
cetuximab, cisplatin, capecitabine
Gastric Cancer
Epclusa
Lung Diseases
acetominophen
Migraine
FLOT
Esophagogastric Adenocarcinoma
Afatinib
Carcinoma, Non-Small-Cell Lung
Hyperpolarized 13C-Pyruvate
Neuroendocrine Tumors
Cyklokapron(R)
Bloodloss
IMG-7289
Thrombocythemia, Essential
cis/carboplatin and etoposide
Small Cell Lung Cancer (SCLC)
Leucovorin (LV) or levoleucovorin
Colorectal Cancer
Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV∆G-ZEBOV-GP)
Ebola Virus Disease
PR51 (6, 10)
Bacterial Infections; Virus Diseases
GX-I7
Triple Negative Breast Cancer
PR51 (6, 15)
Bacterial Infections; Virus Diseases
L-377202
Hormone Refractory Prostate Cancer
Pembrolizumab(KEYTRUDA®)
Triple Negative Breast Cancer
pembrolizumab (KEYTRUDA®)
Advanced Solid Tumors
MK-0646
Neuroendocrine Tumors
Ibutamoren Mesylate (MK-0677)
Fibromyalgia
Pembrolizumab, Cetuximab
HNSCC
TILT-123
Platinum-refractory Ovarian Carcinoma
KEYTRUDA® (pembrolizumab)
Solid Tumor, Adult
anti-IGF-1R recombinant monoclonal antibody MK-0646
Lung Cancer
Pembrolizumab IV infusion Q3W, with daily oral Olaparib
Relapsed Peripheral T-Cell Lymphoma
Cisplatin/Carboplatin; 5FU
Head and Neck Cancer
Other Parkinson's Disease treatments
Parkinson Disease
Abraxane
Non-small Cell Lung Cancer
Cetuximab (Erbitux)
Cancer
FOLFOX-4+cetuximab
Colorectal Cancer
Capecitabine/5-FU
Colorectal Cancer
Arm B Pemetrexed, Cisplatin and MK-0646
Non Small Cell Lung Cancer
quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine or nonavalent human papillomavirus vaccine (HPV 6, 11, 16, 18, 31, 33, 45, 52, 58)
Cancer Survivor
Nesuparib
Endometrial Cancer
Odetiglucan
Colorectal Adenocarcinoma Metastatic in the Liver
Emtricitabine (FTC)/Tenofovir Disoproxil (TDF)
Primary Biliary Cholangitis
pTVG-AR
Castration-resistant Prostate Cancer
V114 Non-adjuvanted
Pneumococcal Infections
rVSVΔG-ZEBOV-GP, V920
Ebola Virus Disease
Ataluren + Pembrolizumab
Colorectal Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
KEYTRUDA® | Approved | Cervical Cancer | - | - |
ANV600 + pembrolizumab (KEYTRUDA®) | Approved | Advanced Solid Tumor | - | - |
TU2218 + KEYTRUDA® (Pembrolizumab) | Approved | Solid Tumor | - | - |
Glipizide | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Cladribine Low Dose | Phase 3 | Generalized Myasthenia Gravis | - | - |
Colistimethate sodium (CMS) | Phase 3 | Bacterial Infections | - | - |
Acarbose | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Rebif® New Formulation (IFN-beta-1a, RNF) | Phase 3 | Multiple Sclerosis, Relapsing-Remitting | - | - |
Patritumab Deruxtecan | Phase 3 | Malignant Neoplasm | - | - |
M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX® | Phase 3 | Measles | - | - |
regorafenib | Phase 3 | Colorectal Cancer | - | - |
Fluorouracil (5-FU) | Phase 3 | Urinary Bladder Neoplasms | - | - |
Elbasvir/Grazoprevir Fixed Dose Combination | Phase 3 | Chronic HCV Infection | - | - |
Rizatriptan co-administered with Acetaminophen | Phase 3 | Migraine | - | - |
Peginterferon alfa-2b (PEG) | Phase 3 | Hepatitis C, Chronic | - | - |
sitagliptin phosphate (+) metformin hydrochloride | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine | Phase 3 | HPV Infections | - | - |
2XP HEPTAVAX™-II SC | Phase 3 | Hepatitis B | - | - |
Ribavirin (SCH 18908) | Phase 3 | Hepatitis C, Chronic | - | - |
V110, pneumococcal vaccine polyvalent | Phase 3 | Healthy | - | - |
montelukast sodium | Phase 3 | Asthma | - | - |
R-DXD | Phase 3 | Lung Neoplasm | - | - |
Rocuronium bromide (Zemuron) | Phase 3 | Anesthesia | - | - |
Gardasil | Phase 3 | Papillomavirus Infections | - | - |
Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine | Phase 3 | Cervical Cancer | - | - |
ART | Phase 3 | HIV-1 Infection | - | - |
Pegylated interferon alfa-2b (PegIntron) | Phase 3 | Hepatitis B, Chronic (CHB) | - | - |
Sitagliptin plus metformin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
DOR | Phase 3 | HIV-1 Infection | - | - |
M-M-R®II | Phase 3 | Pneumococcal Infections | - | - |
Linezolid | Phase 3 | Pneumonia | - | - |
liposomal doxorubicin | Phase 3 | Breast Neoplasms | - | - |
diquafosol tetrasodium (INS365) ophthalmic solution | Phase 3 | Dry Eye Disease | - | - |
denufosol tetrasodium (INS37217) Inhalation Solution | Phase 3 | Cystic Fibrosis | - | - |
succinylcholine | Phase 3 | Neuromuscular Blockade | - | - |
Intismeran | Phase 3 | Non-small Cell Lung Cancer | - | - |
MK-1084 | Phase 3 | Colon Adenocarcinoma | - | - |
AzaSite | Phase 3 | Bacterial Conjunctivitis | - | - |
rosiglitazone | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Cyclophosphamide | Phase 3 | Metastatic Breast Cancer | - | - |
VARIVAX™ New Seed Process | Phase 3 | Varicella | - | - |
peg-IFN | Phase 3 | Hepatitis C, Chronic | - | - |
Sofosbuvir | Phase 3 | Hepatitis C | - | - |
Pneumococcal Vaccine, Polyvalent (23-valent) | Phase 3 | Pneumococcal Infection | - | - |
Reformulated Raltegravir | Phase 3 | HIV Infection | - | - |
Ribavirin (RBV) | Phase 3 | Hepatitis C, Chronic | - | - |
simvastatin/ezetimibe | Phase 3 | Hyperlipidemia | - | - |
Cetrorelix acetate | Phase 3 | Polycystic Ovarian Syndrome | - | - |
REBETOL (ribavirin; SCH 18908) | Phase 3 | Hepatitis C, Chronic | - | - |
Background PAH Therapy | Phase 3 | Pulmonary Arterial Hypertension | - | - |
RotaTeq™ - Rotavirus Vaccine, Live, Oral, Pentavalent | Phase 3 | Vomiting | - | - |
levoleucovorin | Phase 3 | Esophageal Squamous Cell Carcinoma (ESCC) | - | - |
losartan potassium + hydrochlorothiazide + amlodipine besylate (MK-0954E) | Phase 3 | Hypertension | - | - |
V503 Vaccine | Phase 3 | Papillomavirus Infections | - | - |
boceprevir (SCH 503034) | Phase 3 | Chronic Hepatitis C | - | - |
V110 | Phase 3 | Pneumococcal Infection | - | - |
Tivantinib | Phase 3 | Advanced Solid Tumors | - | - |
Cetuximab plus Platinum-based Doublet Chemotherapy | Phase 3 | Non-Small Cell Lung Cancer (NSCLC) | - | - |
Saizen® A | Phase 3 | Children Born With Serious Intra-uterine Growth Retardation | - | - |
vinflunine | Phase 3 | Urothelial Cancer | - | - |
MK-0524B | Phase 3 | Primary Hypercholesterolemia | - | - |
Sevoflurane | Phase 3 | Muscle Relaxation | - | - |
LdT (Telbivudine) and lamivudine | Phase 3 | Hepatitis B | - | - |
BIC/FTC/TAF | Phase 3 | HIV-1 Infection | - | - |
lovastatin | Phase 3 | Atherosclerosis | - | - |
L-PZQ ODT | Phase 3 | Schistosomiasis | - | - |
daptomycin | Phase 3 | Pneumonia, Bacterial | - | - |
Tenofovir + lamivudine + raltegravir | Phase 3 | HIV-1 Infection | - | - |
MK-8748 | Phase 3 | Diabetic Retinopathy | - | - |
HIBERIX™ | Phase 3 | Pneumococcal Infections | - | - |
MMRV (AMP) | Phase 3 | Measles | - | - |
Folinic Acid | Phase 3 | Metastatic Colorectal Cancer | - | - |
Lamivudine | Phase 3 | HIV Infections | - | - |
RotaTeq™ experimental formulation | Phase 3 | Rotavirus Gastroenteritis | - | - |
Modified Process Hepatitis B Vaccine | Phase 3 | Hepatitis B | - | - |
Ifinatamab Deruxtecan | Phase 3 | Castration-Resistant Prostatic Cancer | - | - |
MK0557 | Phase 3 | Obesity | - | - |
Bomedemstat | Phase 3 | Thrombocythemia, Essential | - | - |
Sulfonylurea | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Pembrolizumab (MK-3475) | Phase 3 | Merkel Cell Carcinoma | - | - |
Zidovudine | Phase 3 | HIV Infections | - | - |
MK-0518 | Phase 3 | HIV Infections | - | - |
alvimopan | Phase 3 | Ileus | - | - |
Kuvan® | Phase 3 | Phenylketonuria | - | - |
Tulisokibart | Phase 3 | Hidradenitis Suppurativa | - | - |
luspatercept | Phase 3 | B-Thalassemia | - | - |
Pioglitazone hydrochloride | Phase 3 | Type 2 Diabetes Mellitus | - | - |
BCG | Phase 3 | Urinary Bladder Neoplasms | - | - |
Rebif® | Phase 3 | Clinically Isolated Syndrome | - | - |
Zoster Vaccine, Live (Oka-Merck) | Phase 3 | Varicella Virus Infection | - | - |
Nemtabrutinib | Phase 3 | Chronic Lymphocytic Leukemia | - | - |
Grazoprevir/Elbasvir fixed-dose combination | Phase 3 | Chronic Hepatitis C | - | - |
Zoster Vaccine, Live (Oka-Merck), ZOSTAVAX™ | Phase 3 | Herpes Zoster | - | - |
Prevnar 13® | Phase 3 | Streptococcus Pneumoniae Infection | - | - |
Pembrolizumab Formulated with Berahyaluronidase Alfa | Phase 3 | Metastatic Non-small Cell Lung Cancer | - | - |
Extended-release niacin (ERN) | Phase 3 | Dyslipidemia | - | - |
Prevnar 13™ | Phase 3 | Pneumococcal Infections | - | - |
Pneumovax™ 23 | Phase 3 | Pneumococcal Infections | - | - |
MK0831 | Phase 3 | HIV Infections | - | - |
RotaTeq (V260) | Phase 3 | Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9 | - | - |
Preservative-Free Tafluprost | Phase 3 | Open-angle Glaucoma | - | - |
Palivizumab | Phase 3 | RSV Infection | - | - |
Posaconazole | Phase 3 | Mycoses | - | - |
Rotateq™ | Phase 3 | Rotavirus Infections | - | - |
Clesrovimab | Phase 3 | Respiratory Syncytial Viruses | - | - |
ProQuad (Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live) | Phase 3 | Measles | - | - |
Metformin - Rescue | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Filgrastim | Phase 3 | Metastatic Non-small Cell Lung Cancer | - | - |
Infanrix® hexa | Phase 3 | Varicella | - | - |
granisetron | Phase 3 | Chemotherapy-induced Nausea and Vomiting (CINV) | - | - |
MK-8527 | Phase 3 | Human Immunodeficiency Virus (HIV) | - | - |
PCV15 - Part B | Phase 3 | Pneumococcal Disease | - | - |
Zoster Vaccine, Live (Zostavax™) | Phase 3 | Shingles | - | - |
Zilovertamab vedotin | Phase 3 | B-cell Acute Lymphoblastic Leukemia | - | - |
Doravirine, Tenofovir, Lamivudine | Phase 3 | HIV-1 Infection | - | - |
Pembrolizumab/Quavonlimab | Phase 3 | Colorectal Cancer | - | - |
MK-5172A | Phase 3 | Chronic Hepatitis C | - | - |
PegIntron (peginterferon alfa-2b; SCH 54031) | Phase 3 | Hepatitis | - | - |
Grazoprevir | Phase 3 | Chronic Hepatitis C (CHC) | - | - |
IV Tulisokibart | Phase 3 | Crohn's Disease | - | - |
PEG-Intron | Phase 3 | Hepatitis C | - | - |
Granulocyte Colony-Stimulating Factor (G-CSF) | Phase 3 | DLBCL | - | - |
MK0217, alendronate sodium | Phase 3 | Osteoporosis | - | - |
DOR/ISL | Phase 3 | HIV Infection | - | - |
Emtricitabine/tenofovir disoproxil (FTC/TDF) | Phase 3 | Human Immunodeficiency Virus (HIV) | - | - |
Zoster Vaccine, Live | Phase 3 | Herpes Zoster | - | - |
Efprezimod alfa | Phase 3 | Graft Versus Host Disease | - | - |
Zoster Vaccine, Live (AMP) | Phase 3 | Herpes Zoster | - | - |
Gonalef® (Follitropin alfa) | Phase 3 | Infertility | - | - |
Cisplatin/Carboplatin | Phase 3 | Carcinoma, Squamous Cell of Head and Neck | - | - |
Rocuronium bromide (Org 9426) | Phase 3 | Muscle Relaxation | - | - |
Naproxen | Phase 3 | Endometriosis-related Pain | - | - |
ProQuad® manufactured with recombinant Human Albumin (rHA) | Phase 3 | Measles | - | - |
Gardasil™ | Phase 3 | Papillomavirus Infections | - | - |
Varicella Virus Vaccine Live (Oka-Merck) | Phase 3 | Varicella | - | - |
Fosaprepitant dimeglumine | Phase 3 | Chemotherapy-Induced Nausea and Vomiting (CINV) | - | - |
V181 | Phase 3 | Healthy | - | - |
Human Papillomavirus (HPV) 16 Monovalent | Phase 3 | Cervical Cancer | - | - |
PegIntron | Phase 3 | Hepatitis C | - | - |
Atropine | Phase 3 | Anesthesia, General | - | - |
Glycemic Rescue 1 | Phase 3 | Diabetes Mellitus | - | - |
RECOMBIVAX HB™ | Phase 3 | Pneumococcal Infections | - | - |
Sitagliptin + Pioglitazone | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Axitinib | Phase 3 | Renal Cell Carcinoma | - | - |
fidaxomicin | Phase 3 | Clostridium Difficile-Associated Diarrhea (CDAD) | - | - |
Rocuronium intubating | Phase 3 | Anesthesia | - | - |
Androgen Deprivation Therapy (ADT) | Phase 3 | Metastatic Hormone-Sensitive Prostate Cancer | - | - |
Rocuronium bolus maintenance | Phase 3 | Anesthesia | - | - |
Glimerpiride | Phase 3 | Type 2 Diabetes Mellitus | - | - |
losartan potassium | Phase 3 | Hypertension | - | - |
anacetrapib | Phase 3 | Coronary Heart Disease (CHD) | - | - |
MK0524A | Phase 3 | Flushing | - | - |
V114 | Phase 3 | Pneumococcal Infections | - | - |
Cisplatin (as radiosensitizer) | Phase 3 | Endometrial Neoplasms | - | - |
Vecuronium | Phase 3 | Anesthesia, General | - | - |
Suvorexant Low Dose (LD) | Phase 3 | Primary Insomnia | - | - |
Peginterferon alfa-2b (PEG2b) | Phase 3 | Hepatitis C, Chronic | - | - |
sitagliptin phosphate | Phase 3 | Type 2 Diabetes | - | - |
Peg-interferon alfa-2b | Phase 3 | Hepatitis C, Chronic | - | - |
dorzolamide hydrochloride (+) timolol maleate | Phase 3 | Glaucoma | - | - |
peg-Interferon alfa-2a | Phase 3 | Hepatitis C, Chronic | - | - |
Calderasib | Phase 3 | Non-small Cell Lung Cancer | - | - |
ZOSTAVAX | Phase 3 | Herpes Zoster | - | - |
Relebactam | Phase 3 | Intra-abdominal Infections | - | - |
Infliximab | Phase 3 | Psoriasis | - | - |
(Gardasil™) human papillomavirus (types 6, 11, 16, 18) recombinant vaccine | Phase 3 | Condylomata Acuminata | - | - |
rofecoxib | Phase 3 | Prostate Cancer | - | - |
Peginterferon | Phase 3 | Multiple Myeloma | - | - |
M-M-R II™ | Phase 3 | Varicella | - | - |
Oral Switch | Phase 3 | Suspected or Documented Gram-negative Bacterial Infection | - | - |
H2 Receptor Antagonist | Phase 3 | Non-small Cell Lung Cancer (NSCLC) | - | - |
RotaTeq® | Phase 3 | Meningitis, Meningococcal | - | - |
ProQuad® | Phase 3 | Measles | - | - |
MK0991, caspofungin acetate/Duration of Treatment | Phase 3 | Fungal Infection | - | - |
Sitagliptin/simvastatin FDC | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Pre-treatment with rLH (Luveris) | Phase 3 | Infertility, Female | - | - |
Cilastatin | Phase 3 | Bacterial Pneumonia | - | - |
Pegylated filgrastim | Phase 3 | Metastatic Non-small Cell Lung Cancer | - | - |
IV golimumab | Phase 3 | Arthritis, Rheumatoid | - | - |
RotaTeq™, rotavirus vaccine, live, oral, pentavalent | Phase 3 | Rotavirus Infections | - | - |
Quadrivalent Human Papillomavirus (HPV, Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®) | Phase 3 | Papillomavirus Infections | - | - |
Boceprevir (BOC) | Phase 3 | Chronic Hepatitis C | - | - |
Intismeran autogene | Phase 3 | Bladder Cancer | - | - |
MK0869, aprepitant | Phase 3 | Postoperative Nausea and Vomiting | - | - |
Infliximab + methotrexate (IFX + MTX) | Phase 3 | Arthritis, Psoriatic | - | - |
Rebif New Formulation + prophylactic Ibuprofen | Phase 3 | Relapsing Multiple Sclerosis | - | - |
Metformin IR | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Pembrolizumab/Vibostolimab Co-Formulation | Phase 3 | Small Cell Lung Carcinoma | - | - |
Voriconazole | Phase 3 | Aspergillosis | - | - |
Short ragweed pollen allergen extract | Phase 3 | Rhinitis, Allergic, Seasonal | - | - |
MK0803, lovastatin | Phase 3 | Hypercholesterolemia | - | - |
Aprepitant | Phase 3 | Post-operative Nausea | - | - |
MK-3475A | Phase 3 | Non-small Cell Lung Cancer | - | - |
PPSV23 | Phase 3 | Pneumococcal Disease | - | - |
Trifluridine-Tipiracil | Phase 3 | Gastroesophageal Cancer | - | - |
Rescue medication | Phase 3 | Non-Muscle Invasive Bladder Cancer | - | - |
Tisotumab Vedotin | Phase 3 | Cervical Cancer | - | - |
Pembrolizumab (K) | Phase 3 | Breast Cancer | - | - |
Zoster Vaccine Live | Phase 3 | Herpes Zoster | - | - |
niacin (+) laropiprant | Phase 3 | Hypercholesterolemia | - | - |
TAS-102 (trifluridine and tipiracil) | Phase 3 | Colorectal Neoplasms | - | - |
favezelimab/pembrolizumab | Phase 3 | Hodgkin Lymphoma | - | - |
Golimumab | Phase 3 | Spondylitis, Ankylosing | - | - |
zoster vaccine live (ZOSTAVAX™) | Phase 3 | Herpes Zoster | - | - |
Diquafosol tetrasodium ophthalmic | Phase 3 | Dry Eye Disease | - | - |
Granulocyte colony stimulating factor: Filgrastim or Pegfilgrastim | Phase 3 | Triple Negative Breast Neoplasms | - | - |
TAS-102 | Phase 3 | Colorectal Cancer | - | - |
Infliximab + methotrexate (MTX) | Phase 3 | Arthritis, Rheumatoid | - | - |
Montelukast | Phase 3 | Asthma | - | - |
Boceprevir | Phase 3 | Chronic Hepatitis C Genotype 1 | - | - |
Ensifentrine | Phase 3 | COPD | - | - |
Epirubicin | Phase 3 | Triple Negative Breast Neoplasms | - | - |
Enlicitide | Phase 3 | Hyperlipidemia | - | - |
Esmirtazapine | Phase 3 | Insomnia | - | - |
Pergoveris® | Phase 3 | Infertility | - | - |
Meropenem | Phase 3 | Healthcare-Associated Pneumonia | - | - |
ER niacin/laropiprant | Phase 3 | Diabetes Mellitus Type 2 | - | - |
PNEUMOVAX™23 | Phase 3 | Pneumococcal Infections | - | - |
Enalapril | Phase 3 | Hypertension | - | - |
Tedizolid phosphate | Phase 3 | Acute Bacterial Skin and Skin Structure Infections | - | - |
r-hCG | Phase 3 | Infertility | - | - |
Ceftolozane/Tazobactam | Phase 3 | Complicated Intra-Abdominal Infection | - | - |
hMG | Phase 3 | Infertility | - | - |
Cetuximab + Platinum (Cisplatin or Carboplatin) + 5Fluorouracil (5-FU) | Phase 3 | Head and Neck Cancer | - | - |
Grazoprevir + Elbasvir | Phase 3 | Hepatitis C Infection | - | - |
Cetuximab + concomitant boost radiotherapy | Phase 3 | Squamous Cell Carcinoma of the Head and Neck | - | - |
SC golimumab | Phase 3 | Arthritis, Rheumatoid | - | - |
Voglibose | Phase 3 | Diabetes Mellitus, Non-Insulin-Dependent | - | - |
ER-niacin | Phase 3 | Primary Hypercholesterolaemia | - | - |
MK-1293 | Phase 3 | Type 1 Diabetes Mellitus | - | - |
Bisoprolol/Amlodipine (Bisoprolol failed group) | Phase 3 | Hypertension | - | - |
PAR-101/OPT-80 | Phase 3 | Clostridium Infections | - | - |
ZOSTAVAX™ | Phase 3 | Herpes Zoster | - | - |
cetuximab + cisplatin + vinorelbine | Phase 3 | Non Small Cell Lung Cancer (NSCLC) | - | - |
Ertapenem sodium | Phase 3 | Infection; Diabetic Foot | - | - |
sitagliptin/metformin ≥ | Phase 3 | Type 2 Diabetes Mellitus (T2DM) | - | - |
ER niacin (+) laropiprant (ERN/LRPT) | Phase 3 | Dyslipidemia | - | - |
MK0966 | Phase 3 | Pain, Postoperative Arthroscopy | - | - |
MK0966; Rofecoxib | Phase 3 | Colorectal Adenoma | - | - |
Decadron | Phase 3 | Malignant Neoplasms of Male Genital Organs | - | - |
L50/H12.5/A5 | Phase 3 | Hypertension | - | - |
Frespaciguat | Phase 3 | Pulmonary Hypertension | - | - |
MK0826 | Phase 3 | Complicated Intra-Abdominal Infections | - | - |
sugammadex | Phase 3 | Neuromuscular Blockade | - | - |
pneumococcal 23v polysaccharide vaccine | Phase 3 | Pneumococcal Infection | - | - |
niacin (+) laropiprant (+) simvastatin | Phase 3 | Primary Hypercholesterolemia | - | - |
Modified Process Hepatitis B Vaccine (Experimental) | Phase 3 | Hepatitis B | - | - |
Pembrolizumab/Vibostolimab | Phase 3 | Lung Neoplasms | - | - |
Tedizolid Phophate | Phase 3 | Skin Diseases, Infectious | - | - |
MK0507A, dorzolamide hydrochloride (+) timolol maleate | Phase 3 | Glaucoma | - | - |
Finasteride | Phase 3 | Enlarged Prostate | - | - |
raltegravir | Phase 3 | HIV | - | - |
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL™) | Phase 3 | Papillomavirus Infections | - | - |
V212 | Phase 3 | Herpes Zoster | - | - |
raltegravir potassium | Phase 3 | HIV Infections | - | - |
rotavirus vaccine, live, oral, pentavalent | Phase 3 | Rotavirus Infections | - | - |
Combination of pegylated interferon alfa-2b and ribavirin | Phase 3 | Hepatitis C, Chronic | - | - |
Dexamethasone | Phase 3 | Non-Small-Cell Lung Carcinoma | - | - |
Measles, Mumps, and Rubella Virus Vaccine Live (MMR) | Phase 3 | Varicella | - | - |
Grazoprevir/Elbasvir | Phase 3 | Hepatitis C | - | - |
MK0217A, alendronate sodium (+) cholecalciferol | Phase 3 | Osteoporosis | - | - |
hydrochlorothiazide (HCTZ) | Phase 3 | Hypertension | - | - |
pembrolizumab | Phase 3 | Colorectal Neoplasms | - | - |
Open-label Metformin | Phase 3 | Type 2 Diabetes | - | - |
loratadine; montelukast | Phase 3 | Rhinitis, Allergic, Seasonal | - | - |
Recombinant Human Papillomavirus Nonavalent Vaccine | Phase 3 | AIDS-Related Human Papillomavirus Infection | - | - |
caspofungin acetate | Phase 3 | Fungal Infection | - | - |
Isentress® | Phase 3 | HIV Infections | - | - |
Acid Nicotinique | Phase 3 | Acute Coronary Syndrome (ACS) | - | - |
laropiprant/niacin (MK0524A) | Phase 3 | Hypercholesterolemia | - | - |
Sitagliptin | Phase 3 | Hyperlipidemia | - | - |
9vHPV vaccine | Phase 3 | Papillomavirus Infections | - | - |
2XP HEPTAVAX™-II IM | Phase 3 | Hepatitis B | - | - |
Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live | Phase 3 | Measles | - | - |
Olaparib | Phase 3 | Ovarian Cancer | - | - |
Mitomycin C (MMC) | Phase 3 | Urinary Bladder Neoplasms | - | - |
Lantus™ | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Gonal-f® | Phase 3 | Assisted Reproductive Techniques | - | - |
IPV | Phase 3 | Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9 | - | - |
FTC/TDF + EFV or LPV/R +T20 | Phase 3 | HIV Infections | - | - |
Human Chorionic Gonadotropin (hCG) | Phase 3 | Luteal Hormone Supplementation in In-vitro Fertilization | - | - |
Ropeginterferon alfa-2b | Phase 3 | Polycythemia Vera | - | - |
7-valent pneumococcal-CRM197 conjugate vaccine | Phase 3 | Otitis Media | - | - |
COL-1620 | Phase 3 | Luteal Hormone Supplementation in In-vitro Fertilization | - | - |
V441, diptheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant), & Haemophilus influenza type b conjugate vaccine | Phase 3 | Diphtheria | - | - |
Stavudine | Phase 3 | HIV Infections | - | - |
Glycemic Rescue | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Raptiva | Phase 3 | Moderate to Severe Psoriasis | - | - |
M-M-R II® | Phase 3 | Varicella | - | - |
mRNA-1273 Vaccine | Phase 3 | Papillomavirus Infections | - | - |
V501 | Phase 3 | Human | - | - |
Rescue Medications | Phase 3 | Cervical Cancer | - | - |
MTX | Phase 3 | Arthritis, Rheumatoid | - | - |
Vancomycin (or equivalent) | Phase 3 | Acute Hematogenous Osteomyelitis | - | - |
Insulin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Ezetimibe | Phase 3 | Hypercholesterolemia | - | - |
Preladenant | Phase 3 | Parkinson Disease | - | - |
Calcium supplement | Phase 3 | Osteoporosis | - | - |
oral contraceptive pill pretreatment (Marvelon) | Phase 3 | Infertility, Female | - | - |
V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine | Phase 3 | Cervical Cancer | - | - |
V920 Consistency Lot A | Phase 3 | Prevention of Ebola Infection | - | - |
Peginterferon alfa-2a | Phase 3 | Hepatitis C, Chronic | - | - |
sitagliptin/metformin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Letermovir | Phase 3 | Cytomegalovirus Infection | - | - |
Opevesostat | Phase 3 | Prostate Cancer Metastatic | - | - |
Sotatercept | Phase 3 | Pulmonary Arterial Hypertension | - | - |
Bezlotoxumab | Phase 3 | Clostridium Difficile Infection | - | - |
V232 Modified Process Hepatitis B Vaccine: Lot A | Phase 3 | Hepatitis B Infection | - | - |
Riociguat (Adempas, BAY63-2521) | Phase 3 | Hypertension, Pulmonary | - | - |
PCV20 | Phase 3 | Pneumococcal Infection | - | - |
PCV13 | Phase 3 | Pneumococcal Infections | - | - |
Pentacel™ | Phase 3 | Pneumococcal Infections | - | - |
losartan potassium (+) hydrochlorothiazide | Phase 3 | Hypertension | - | - |
V260 | Phase 3 | Rotavirus Gastroenteritis | - | - |
Varicella Virus Vaccine Live (2007 Process) (Oka/Merck) | Phase 3 | Varicella | - | - |
Prednisone | Phase 3 | Prostate Cancer Aggressiveness | - | - |
Ezetimibe/Simvastatin | Phase 3 | Type 1 Diabetes Mellitus | - | - |
ISL/ULO | Phase 3 | Human Immunodeficiency Virus Type 1 (HIV-1) Infection | - | - |
Ertugliflozin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Interferon-alpha2b - 1 year | Phase 3 | Melanoma | - | - |
Varicella-zoster vaccine | Phase 3 | Herpes Zoster | - | - |
Cladribine (MAVENCLAD®) | Phase 3 | Advanced Multiple Sclerosis | - | - |
Tobramycin | Phase 3 | Bacterial Conjunctivitis | - | - |
Pegylated interferon alfa-2b | Phase 3 | Hepatitis C | - | - |
Peginterferon alfa-2b | Phase 3 | Carcinoma, Hepatocellular | - | - |
Ipragliflozin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Rocuronium bromide | Phase 3 | Anesthesia | - | - |
IMI/REL | Phase 3 | Suspected or Documented Gram-negative Bacterial Infection | - | - |
MK0966, rofecoxib | Phase 3 | Postoperative Pain | - | - |
Basal Insulin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Posaconazole oral suspension | Phase 3 | Mycoses | - | - |
sac-TMT | Phase 3 | Non-small Cell Lung Cancer | - | - |
Grazoprevir/Elbasvir FDC tablet (MK-5172A) | Phase 3 | Chronic Hepatitis C | - | - |
Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin | Phase 3 | Hepatitis C, Chronic | - | - |
Org 50081 | Phase 3 | Insomnia | - | - |
budesonide and montelukast | Phase 3 | Obstructive Sleep Apnea | - | - |
Avonex® | Phase 3 | Multiple Sclerosis, Relapsing-Remitting | - | - |
Corifollitropin Alfa | Phase 3 | Infertility, Female | - | - |
Follitropin alfa liquid formulation | Phase 3 | Infertility | - | - |
Metronidazole | Phase 3 | Complicated Intra-abdominal Infections | - | - |
Ritonavir | Phase 3 | HIV Infections | - | - |
Vericiguat tablet | Phase 3 | Heart Failure | - | - |
Micronised Progesterone | Phase 3 | Infertility | - | - |
HBVAXPRO™ | Phase 3 | Hepatitis B | - | - |
Paclitaxel | Phase 3 | Non-small Cell Lung Cancer | - | - |
VARIVAX™ | Phase 3 | Varicella | - | - |
Levocarnitine | Phase 3 | HIV Infections | - | - |
SC Tulisokibart | Phase 3 | Ulcerative Colitis | - | - |
Imipenem+Cilastatin/Relebactam | Phase 3 | Complicated Intra-abdominal Infection | - | - |
Etoricoxib | Phase 3 | Knee Osteoarthritis | - | - |
MK0826, ertapenem sodium | Phase 3 | Infections | - | - |
Elbasvir | Phase 3 | Hepatitis C | - | - |
Vericiguat | Phase 3 | Heart Failure | - | - |
Doravirine | Phase 3 | HIV-1 | - | - |
DAPTACEL™ | Phase 3 | Bacterial Infections | - | - |
Telcagepant | Phase 3 | Migraine | - | - |
Pembrolizumab (+) Berahyaluronidase alfa | Phase 3 | Lung Cancer | - | - |
Fidaxomicin tablets | Phase 3 | Clostridium Difficile-associated Diarrhea (CDAD) | - | - |
IMI/REL FDC | Phase 3 | Hospital-Acquired Bacterial Pneumonia | - | - |
MMR II™ | Phase 3 | Pneumococcal Infections | - | - |
Zanzalintinib | Phase 3 | Renal Cell Carcinoma | - | - |
Gardasill 9™ vaccine | Phase 3 | Neoplasia | - | - |
MK0974 | Phase 3 | Migraine | - | - |
sitagliptin/pioglitazone q.d | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Lenvatinib | Phase 3 | Non-small Cell Lung Cancer | - | - |
raltegravir (Isentress) | Phase 3 | HIV Infections | - | - |
week 24 | Phase 3 | Peripheral Spondyloarthritis | - | - |
Fludrocortisone acetate | Phase 3 | Prostate Cancer Metastatic | - | - |
V503 (9-valent Human Papillomavirus L1 Virus-Like Particle vaccine) | Phase 3 | Human Papillomavirus Infection | - | - |
V116 | Phase 3 | Pneumococcal Infection | - | - |
Omarigliptin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Vicriviroc | Phase 3 | HIV Infections | - | - |
Molnupiravir | Phase 3 | Coronavirus Disease (COVID-19) | - | - |
MR Prednisone | Phase 3 | Rheumatoid Arthritis | - | - |
ertapenem sodium (MK0826) | Phase 3 | Urinary Tract Infection | - | - |
Pegylated liposomal doxorubicin (SCH 200746) | Phase 3 | Breast Cancer | - | - |
VAQTA™ | Phase 3 | Pneumococcal Infections | - | - |
peginterferon alfa-2b (SCH 54031) | Phase 3 | Chronic Hepatitis C | - | - |
Pembrolizumab SC | Phase 3 | Non-Small Cell Lung Cancer | - | - |
9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) | Phase 3 | HPV Positive Oropharyngeal Squamous Cell Carcinoma | - | - |
ISL | Phase 3 | Human Immunodeficiency Virus Type 1 (HIV-1) Infection | - | - |
MK-6072 | Phase 3 | Clostridium Difficile Infection | - | - |
TR-701 FA | Phase 3 | Skin and Subcutaneous Tissue Bacterial Infections | - | - |
sodium chloride (NaCl) | Phase 3 | Anesthesia | - | - |
Combination of (a) pegylated interferon alfa-2b and (b) rebetol | Phase 3 | Liver Transplantation | - | - |
Pegylated interferon alfa-2b (SCH 54031) | Phase 3 | Hepatitis C, Chronic | - | - |
Neostigmine | Phase 3 | Anesthesia | - | - |
5-Fluorouracil | Phase 3 | Uterine Cervical Neoplasms | - | - |
CB-183,315 | Phase 3 | Clostridium Difficile Infection | - | - |
INFANRIX™ hexa | Phase 3 | Bacterial Infections | - | - |
PR5I | Phase 3 | Neisseria Meningitidis | - | - |
Gefapixant | Phase 3 | Chronic Cough | - | - |
Gliclazide | Phase 3 | Type 2 Diabetes Mellitus | - | - |
ceftriaxone sodium | Phase 3 | Infection | - | - |
PCV15 | Phase 3 | Pneumonia, Pneumococcal | - | - |
TRUVADA® | Phase 3 | HIV Infections | - | - |
eribulin | Phase 3 | Metastatic Triple Negative Breast Cancer | - | - |
Indinavir sulfate | Phase 3 | HIV Infections | - | - |
Delstrigo | Phase 3 | HIV-1-infection | - | - |
ezetimibe with simvastatin | Phase 3 | Hypercholesterolemia | - | - |
Ridaforolimus | Phase 3 | Sarcoma | - | - |
V503 | Phase 3 | Papillomavirus Infections | - | - |
MK-0524A | Phase 3 | Hypercholesteremia | - | - |
Saizen® | Phase 3 | Fibromyalgia | - | - |
Supportive care measures | Phase 3 | Non-small Cell Lung Cancer (NSCLC) | - | - |
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live | Phase 3 | Measles | - | - |
Recombinant human luteinizing hormone (r-hLH) | Phase 3 | Hypogonadism | - | - |
mFOLFOX6 | Phase 3 | Colorectal Carcinoma | - | - |
alendronate with cholecalciferol | Phase 3 | Osteoporosis | - | - |
Sitagliptin (MK0431) | Phase 3 | Diabetes Mellitus, Type II | - | - |
Ezetimibe + Atorvastatin | Phase 3 | Hypercholesterolemia | - | - |
Efavirenz | Phase 3 | HIV Infections | - | - |
V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine/Duration of Treatment: 4 years | Phase 3 | Cervical Cancer | - | - |
Peginterferon alfa-2b (PegIntron, SCH 54031) | Phase 3 | Hepatitis D, Chronic | - | - |
RNF | Phase 3 | Multiple Sclerosis | - | - |
ezetimibe (plus simvastatin) | Phase 3 | Atherosclerosis | - | - |
H1 receptor antagonist | Phase 3 | Ovarian Cancer | - | - |
Telcagepant potassium | Phase 3 | Migraine | - | - |
Epacadostat | Phase 3 | Gastric Adenocarcinoma | - | - |
Cisplatin | Phase 3 | Head and Neck Neoplasms | - | - |
Hepatitis A Vaccine, Purified Inactivated (VAQTA™) | Phase 3 | Hepatitis A Virus Infection | - | - |
Enlicitide Decanoate | Phase 3 | Hypercholesterolemia | - | - |
Odanacatib | Phase 3 | Osteoporosis Postmenopausal | - | - |
pegylated interferon alpha-2b | Phase 3 | Hepatitis B, Chronic | - | - |
Rotavirus vaccine | Phase 3 | Bacterial Infections | - | - |
MK-8591A | Phase 3 | HIV-1 Infection | - | - |
Estrogens | Phase 3 | Infertility | - | - |
Interferon-beta-1a | Phase 3 | Hepatitis C | - | - |
Dinaciclib | Phase 3 | Chronic Lymphocytic Leukemia (CLL) | - | - |
Acetaminophen (or equivalent) | Phase 3 | Non-small Cell Lung Cancer (NSCLC) | - | - |
V419 | Phase 3 | Bacterial Infections | - | - |
Suvorexant | Phase 3 | Insomnia | - | - |
Dexamethasone (or equivalent) | Phase 3 | Non-small Cell Lung Cancer (NSCLC) | - | - |
ATRIPLA™ | Phase 3 | Human Immunodeficiency Virus (HIV) | - | - |
MK-1045 | Phase 3 | Lymphoma, Non-Hodgkin | - | - |
Rocuronium maintenance | Phase 3 | Anesthesia | - | - |
Rocuronium | Phase 3 | Anesthesia, General | - | - |
vaniprevir | Phase 3 | Hepatitis C, Chronic | - | - |
Blinatumomab | Phase 3 | B-cell Acute Lymphoblastic Leukemia | - | - |
Anagrelide | Phase 3 | Essential Thrombocythemia | - | - |
Steroid Mouthwash (dexamethasone or equivalent) | Phase 3 | Non-small Cell Lung Cancer (NSCLC) | - | - |
ULO | Phase 3 | Human Immunodeficiency Virus Type 1 (HIV-1) Infection | - | - |
ZOSTAVAX™ (concomitant) | Phase 3 | Herpes Zoster | - | - |
Enpatoran | Phase 3 | Systemic Lupus Erythematosus (SLE) | - | - |
CXA-201 | Phase 3 | Complicated Urinary Tract Infection | - | - |
Telcagepant soft | Phase 3 | Migraine | - | - |
VARIVAX® PE34 Process | Phase 3 | Varicella | - | - |
Rotarix™ | Phase 3 | Pneumococcal Infections | - | - |
Vorinostat | Phase 3 | Mesothelioma | - | - |
Vericiguat suspension | Phase 3 | Heart Failure | - | - |
KOCITAF | Phase 3 | HIV-1-infection | - | - |
M-M-R™ II | Phase 3 | Pneumococcal Infections | - | - |
MK-3415 | Phase 3 | Clostridium Difficile Infection | - | - |
Belzutifan | Phase 3 | Renal Cell Carcinoma | - | - |
Clonidine | Phase 3 | Malignant Neoplasms of Male Genital Organs | - | - |
Lisinopril | Phase 3 | Kidney, Polycystic | - | - |
Leucovorin/levoleucovorin | Phase 3 | Metastatic Colorectal Cancer | - | - |
Rocurium | Phase 3 | Anesthesia, General | - | - |
Surotomycin | Phase 3 | Clostridium Difficile Infection | - | - |
neostigmine and glycopyrrolate or atropine | Phase 3 | Neuromuscular Blockade | - | - |
rolofylline | Phase 3 | Heart Failure, Congestive | - | - |
Epinephrine | Phase 3 | Malignant Neoplasms of Male Genital Organs | - | - |
epinastine nasal spray, low concentration, low dose volume | Phase 3 | Seasonal Allergic Rhinitis | - | - |
Simvastatin | Phase 3 | Cardiovascular Disease | - | - |
INS365 Ophthalmic Solution | Phase 3 | Keratoconjunctivitis Sicca | - | - |
QIV | Phase 3 | Pneumonia, Pneumococcal | - | - |
Letermovir tablet | Phase 3 | Cytomegalovirus Infection | - | - |
peginterferon alfa-2b (PEG2b) (SCH 54031) | Phase 3 | Hepatitis C, Chronic | - | - |
Prulifloxacin | Phase 3 | Acute Gastroenteritis in Adult Travelers | - | - |
Acetaminophen/Paracetamol | Phase 3 | Migraine Disorders | - | - |
clindamycin/ketoconazole vaginal ovule | Phase 3 | Vaginosis, Bacterial | - | - |
Prevenar 13™ | Phase 3 | Pneumococcal Infections | - | - |
Efalizumab | Phase 3 | Moderate to Severe Psoriasis | - | - |
Suvorexant High Dose (HD) | Phase 3 | Primary Insomnia | - | - |
Alviompan | Phase 3 | Bowel Dysfunction | - | - |
FOLFIRI (5-Fluorouracil, Folinic acid, Irinotecan) | Phase 3 | Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer | - | - |
Valganciclovir | Phase 3 | CMV Disease | - | - |
taranabant | Phase 3 | Smoking | - | - |
MK-7625A (ceftolozane/tazobactam) | Phase 3 | Intra-abdominal Infection | - | - |
Uridine 5'-Triphosphate (UTP) Solution for Inhalation | Phase 3 | Lung Cancer | - | - |
Imipenem | Phase 3 | Bacterial Pneumonia | - | - |
S-1 | Phase 3 | Gastric Cancer | - | - |
Glycopyrrolate | Phase 3 | Surgical Procedures, Elective | - | - |
Rotavirus Vaccine, Live, Oral, Pentavalent (V260, RotaTeq™) | Phase 3 | Rotavirus | - | - |
Vaxelis™ | Phase 3 | Pneumococcal Infections | - | - |
V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live | Phase 3 | Measles | - | - |
V501, Gardasil, Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine/Duration of Treatment : 4 Years | Phase 3 | Cervical Cancer | - | - |
RSV-A Memphis 37b | Phase 2 | Respiratory Syncytial Viruses | - | - |
Lonafarnib | Phase 2 | Breast Cancer | - | - |
Pemetrexed Cisplatin | Phase 2 | Non Small Cell Lung Cancer | - | - |
EVX-01 | Phase 2 | Melanoma Stage IV | - | - |
PembroRT | Phase 2 | Non-small Cell Lung Cancer, NSCLC | - | - |
Brexucabtagene autoleucel (other names: brexu-cel, Tecartus) | Phase 2 | Recurrent Mantle Cell Lymphoma | - | - |
MK1903 | Phase 2 | Dyslipidemia | - | - |
MK-2206 | Phase 2 | PANCREAS | - | - |
Peginterferon alfa-2a (Peg-IFN) | Phase 2 | Hepatitis C, Chronic | - | - |
ANV600 | Phase 2 | Advanced Solid Tumor | - | - |
Pembrolizumab/Favezelimab | Phase 2 | Colorectal Cancer | - | - |
Pembrolizumab (for 30 minutes | Phase 2 | Breast Cancer | - | - |
Ritonavir-boosted protease inhibitor | Phase 2 | HIV | - | - |
Uprifosbuvir (+) Grazoprevir (+) Ruzasvir | Phase 2 | Hepatitis C | - | - |
denufosol tetrasodium Inhalation Solution | Phase 2 | Cystic Fibrosis | - | - |
CXA-101 | Phase 2 | Complicated Urinary Tract Infection | - | - |
pegylated interferon | Phase 2 | Chronic Hepatitis C | - | - |
Multiple low dose cyclophosphamide | Phase 2 | Multiple Myeloma | - | - |
Azacitadine | Phase 2 | Acute Myeloid Leukemia | - | - |
Cisplatin (TP) | Phase 2 | Squamous Cell Carcinoma of the Hypopharynx | - | - |
pIL-12 | Phase 2 | Melanoma | - | - |
LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER | Phase 2 | Solid Tumor, Adult | - | - |
LY3537982 | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
Butantan - DV | Phase 2 | Dengue | - | - |
KVA12123 Plus Pembrolizumab - Dose Escalation | Phase 2 | Cancer | - | - |
KVA12123 Plus Pembrolizumab - Dose Expansion | Phase 2 | Cancer | - | - |
denufosol tetrasodium (INS37217) | Phase 2 | Cystic Fibrosis | - | - |
OPT-80 | Phase 2 | Diarrhea | - | - |
Dalotuzumab | Phase 2 | Carcinoma, Non-small-cell Lung | - | - |
MK-8777 | Phase 2 | Depression | - | - |
KVA12123 - Dose Expansion | Phase 2 | Cancer | - | - |
ARQ 197 | Phase 2 | Pancreatic Neoplasms | - | - |
ARQ 501 | Phase 2 | Cancer | - | - |
ADL5945 | Phase 2 | Opioid Induced Constipation | - | - |
Robatumumab | Phase 2 | Colorectal Cancer | - | - |
MK0431, sitagliptin phosphate | Phase 2 | Diabetes Mellitus, Type II | - | - |
M5717 | Phase 2 | Acute Malaria | - | - |
MK0812 | Phase 2 | Arthritis, Rheumatoid | - | - |
Vibostolimab | Phase 2 | Melanoma | - | - |
MK0493 | Phase 2 | Obesity | - | - |
Selumetinib capsule formulation | Phase 2 | Neurofibromatosis Type 1 | - | - |
INS37217 Nasal Spray | Phase 2 | Perennial Allergic Rhinitis | - | - |
MK0777 | Phase 2 | Generalized Anxiety Disorder | - | - |
Uprifosbuvir | Phase 2 | Hepatitis C | - | - |
Pneumococcal Conjugate Vaccine (V114) | Phase 2 | Pneumococcal Infections | - | - |
V114 Aluminum-adjuvanted | Phase 2 | Pneumococcal Infections | - | - |
Vibostolimab/Pembrolizumab | Phase 2 | Carcinoma, Renal Cell | - | - |
MK-3120 | Phase 2 | Urothelial Carcinoma | - | - |
Navarixin | Phase 2 | Solid Tumors | - | - |
Daptomycin for Injection | Phase 2 | Bacteremia | - | - |
UFOX + Cetuximab | Phase 2 | Previously Untreated Metastatic Colorectal Cancer | - | - |
Raludotatug Deruxtecan (R-DXd) | Phase 2 | Gastrointestinal Cancer | - | - |
Tepotinib | Phase 2 | Non-small Cell Lung Cancer | - | - |
TMC647055 | Phase 2 | Chronic Hepatitis C Virus | - | - |
MK-3795 | Phase 2 | VHL Gene Mutation | - | - |
V114 Lot 1 | Phase 2 | Pneumococcal Infections | - | - |
adavosertib | Phase 2 | Ovarian Cancer | - | - |
MK0249 | Phase 2 | Attention-Deficit/Hyperactivity Disorder (ADHD) | - | - |
MK-8435 (Org 25935) | Phase 2 | Schizophrenia | - | - |
MK-6096 | Phase 2 | Migraine | - | - |
Pembrolizumab/vibostolimab coformulation | Phase 2 | Bladder Cancer | - | - |
irinotecan hydrochloride | Phase 2 | Metastatic Colorectal Cancer | - | - |
MK-0941 | Phase 2 | Type 2 Diabetes Mellitus | - | - |
IDX719 | Phase 2 | Hepatitis C, Chronic | - | - |
Ritonavir (RTV) | Phase 2 | Chronic Hepatitis C Virus | - | - |
MK2295 | Phase 2 | Pain, Postoperative | - | - |
Quavonlimab | Phase 2 | Advanced Solid Tumors | - | - |
MK-1167 | Phase 2 | Alzheimer Disease | - | - |
SCH 530348 | Phase 2 | Arterial Obstructive Diseases | - | - |
Epinastine Nasal Spray | Phase 2 | Seasonal Allergic Rhinitis | - | - |
Merck L-830982 | Phase 2 | Schizophrenia | - | - |
MK-4830 | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
zoster vaccine live (Oka/Merck) | Phase 2 | Shingles | - | - |
Raludotatug Deruxtecan | Phase 2 | Ovarian Cancer Recurrent | - | - |
Coformulation favezelimab/pembrolizumab | Phase 2 | Esophageal Squamous Cell Carcinoma (ESCC) | - | - |
Fludrocortisone/Fludrocortisone acetate | Phase 2 | Malignant Neoplasm | - | - |
Fosaprepitant | Phase 2 | Chemotherapy-induced Nausea and Vomiting | - | - |
Farnesyl Protein Transferase Inhibitor | Phase 2 | Leukemia | - | - |
ADL5859 | Phase 2 | Peripheral Neuropathy | - | - |
MK2461 | Phase 2 | Neoplasm | - | - |
MK0991, caspofungin acetate | Phase 2 | Aspergillosis | - | - |
SCH 486757 | Phase 2 | Cough | - | - |
Tecemotide (L-BLP25) | Phase 2 | Lung Neoplasms | - | - |
measles, mumps, and rubella virus vaccine live | Phase 2 | Measles | - | - |
AS900672-Enriched 50 microgram (mcg) | Phase 2 | Infertility | - | - |
Dexamethasone/Dexamethasone acetate | Phase 2 | Malignant Neoplasm | - | - |
Cilengitide | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
ecallantide | Phase 2 | Bloodloss | - | - |
Pembrolizumab (neoadjuvant) | Phase 2 | Lung Neoplasm Malignant | - | - |
MK0518 | Phase 2 | HIV Infections | - | - |
Megestrol acetate/Medroxyprogesterone acetate | Phase 2 | Malignant Neoplasm | - | - |
ENB003 | Phase 2 | Cancer | - | - |
MK-5684 | Phase 2 | Malignant Neoplasm | - | - |
Attenuvax | Phase 2 | HIV Infections | - | - |
M5049 low dose | Phase 2 | Systemic Lupus Erythematosus | - | - |
Pegylated Interferon Alfa | Phase 2 | Chronic Hepatitis C | - | - |
KW-3902IV | Phase 2 | Heart Failure, Congestive | - | - |
Favezelimab | Phase 2 | Advanced Non-Small Cell Lung Cancer | - | - |
tildrakizumab | Phase 2 | Psoriasis | - | - |
SCH 900538 | Phase 2 | Seasonal Allergic Rhinitis | - | - |
EBR/GZR FDC Tablet | Phase 2 | HCV Infection | - | - |
Mavyret | Phase 2 | End Stage Renal Disease | - | - |
MK0916 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
V160 | Phase 2 | Cytomegalovirus (CMV) Infections | - | - |
MK-2140 (zilovertamab vedotin) | Phase 2 | Relapsed or Refractory Diffuse Large B-Cell Lymphoma | - | - |
Cabazitaxel | Phase 2 | Prostatic Neoplasms, Castration-Resistant | - | - |
L-dopa | Phase 2 | Parkinson Disease | - | - |
MK0364 | Phase 2 | Obesity | - | - |
Single low dose cyclophosphamide | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
MK-8189 | Phase 2 | Schizophrenia, Acute Episode | - | - |
Recombinant human growth hormone (r-hGH) | Phase 2 | Hypochondroplasia | - | - |
CyPep-1 | Phase 2 | Advanced Head and Neck Squamous Cell Carcinoma | - | - |
Pembrolizumab and Lenvatinib | Phase 2 | Hepatocellular Carcinoma | - | - |
Boserolimab | Phase 2 | Small Cell Lung Cancer | - | - |
2 NRTIs | Phase 2 | Human Immunodeficiency Virus (HIV) Infection | - | - |
PegIFN-2b | Phase 2 | HIV Infections | - | - |
PegIntron (peginterferon alfa-2b) | Phase 2 | Hepatitis C, Chronic | - | - |
Atorvastatin/niacin extended-release | Phase 2 | Carotid Atherosclerosis | - | - |
Rebif | Phase 2 | Multiple Sclerosis | - | - |
MK-0873 | Phase 2 | Rheumatoid Arthritis | - | - |
Matuzumab | Phase 2 | Esophageal Cancer | - | - |
V504 | Phase 2 | Cervical Cancer | - | - |
imipenem/cilastatin | Phase 2 | Urinary Tract Infections | - | - |
cetuximab, cisplatin | Phase 2 | Breast Neoplasm | - | - |
Interferon beta-1a | Phase 2 | Alzheimer's Disease | - | - |
V114 Medium Dose | Phase 2 | Pneumococcal Infections | - | - |
V181 High-Potency Level | Phase 2 | Dengue Disease | - | - |
cyclophosphamide (CPA) | Phase 2 | Rectal Cancer | - | - |
Biltricide (racemate praziquantel) oral tablets | Phase 2 | Schistosomiasis | - | - |
Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF) | Phase 2 | Infertility Implantation Failure | - | - |
SCH 900636 | Phase 2 | Depressive Disorders | - | - |
Pegylated Lyposomal Doxorubicin | Phase 2 | Breast Neoplasm | - | - |
EMD 525797 | Phase 2 | Metastatic Colorectal Cancer | - | - |
MK0782 | Phase 2 | Stomach Ulcer | - | - |
TR701 FA | Phase 2 | Major Cutaneous Abscess | - | - |
Doravirine, Tenofovir, Lamivudine - Blinded | Phase 2 | HIV-1 | - | - |
V940 | Phase 2 | Squamous Non-small Cell Lung Cancer | - | - |
Efinopegdutide | Phase 2 | Metabolic Dysfunction-Associated Steatotic Liver Disease | - | - |
Cetuximab/avelumab | Phase 2 | Head and Neck Squamous Cell Carcinoma (HNSCC) | - | - |
PRA023 IV | Phase 2 | Crohn Disease | - | - |
Zolinza (vorinostat) | Phase 2 | Lymphoma | - | - |
Metolazone | Phase 2 | Heart Failure | - | - |
PegLiposomal Doxorubicin | Phase 2 | Mesenchymal Tumor | - | - |
ST-067 | Phase 2 | Cancer | - | - |
Miransertib | Phase 2 | PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS) | - | - |
MK-0893 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
GI-101A | Phase 2 | Advanced Solid Tumor | - | - |
ZA | Phase 2 | Breast Cancer | - | - |
L-756423 | Phase 2 | HIV Infections | - | - |
timolol/dorzolamide combination | Phase 2 | Glaucoma | - | - |
AO-176 | Phase 2 | Solid Tumor | - | - |
Esmeron® | Phase 2 | Neuromuscular Blockade | - | - |
NM283 plus Peg-IFNα-2a | Phase 2 | Chronic Hepatitis C | - | - |
MK-2060 | Phase 2 | End-Stage Renal Disease | - | - |
IDX184 | Phase 2 | Chronic Hepatitis C Infection | - | - |
Pleconaril | Phase 2 | Asthma | - | - |
KVA12123 - Dose Escalation | Phase 2 | Cancer | - | - |
Gocatamig | Phase 2 | Small-Cell Lung Cancer | - | - |
MK-1200 | Phase 2 | Advanced Solid Tumors | - | - |
SCH 727965 | Phase 2 | Breast Neoplasms | - | - |
V114-A | Phase 2 | Pneumococcal Infections | - | - |
IFN beta 1a TIW | Phase 2 | Multiple Sclerosis | - | - |
Pegylated Liposomal Doxorubicin | Phase 2 | Breast Neoplasm | - | - |
Lenvatinib Capsules | Phase 2 | Hepatocellular Carcinoma | - | - |
Avastin | Phase 2 | High-grade Serous Ovarian Carcinoma | - | - |
Atacicept | Phase 2 | Rheumatoid Arthritis | - | - |
Vibegron | Phase 2 | Urinary Bladder, Overactive | - | - |
Org 34517 | Phase 2 | Depression | - | - |
MK-1029 | Phase 2 | Asthma | - | - |
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate | Phase 2 | HIV-1 Infection | - | - |
TERN-701 | Phase 2 | Chronic Myeloid Leukemia, Chronic Phase | - | - |
CRS-207 | Phase 2 | Metastatic Pancreatic Adenocarcinoma | - | - |
Lenvatinib Oral Product | Phase 2 | Merkel Cell Carcinoma | - | - |
Coformulated favezelimab/pembrolizumab | Phase 2 | Metastatic Urothelial Carcinoma | - | - |
val-mCyd | Phase 2 | Chronic Hepatitis C | - | - |
Radium-223 | Phase 2 | Prostate Cancer | - | - |
valopicitabine | Phase 2 | Chronic Hepatitis C | - | - |
MK0677 | Phase 2 | Alzheimer's Disease | - | - |
Interferon-beta-1a, 44 microgram | Phase 2 | Ulcerative Colitis | - | - |
MK0991, caspofungin acetate/Duration of Treatment: variable | Phase 2 | Candidiasis | - | - |
Antihistamine | Phase 2 | Esophageal Squamous Cell Carcinoma | - | - |
Oral testosterone undecanoate (Andriol) | Phase 2 | Hypogonadism | - | - |
Dalantercept | Phase 2 | Squamous Cell Carcinoma of the Head and Neck | - | - |
Sugar Pill | Phase 2 | Osteoarthritis of the Knee | - | - |
Vorapaxar | Phase 2 | Atherosclerosis | - | - |
Docetetaxel | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
Pertuzumab | Phase 2 | Breast Neoplasms | - | - |
epinastine | Phase 2 | Allergic Rhinitis | - | - |
MK-8998 | Phase 2 | Schizophrenia | - | - |
ATX-MS-1467 | Phase 2 | Multiple Sclerosis | - | - |
Dalantercept plus sorafenib | Phase 2 | Advanced Adult Hepatocellular Carcinoma | - | - |
Nelfinavir mesylate | Phase 2 | HIV Infections | - | - |
AR51 (12, 10) | Phase 2 | Bacterial Infections; Virus Diseases | - | - |
EV | Phase 2 | Bladder Cancer | - | - |
diphenhydramine | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
MK-8616 | Phase 2 | Neuromuscular Blockade | - | - |
Benznidazole | Phase 2 | Chagas Disease | - | - |
FF-10832 | Phase 2 | Advanced Urothelial Carcinoma | - | - |
raltegravir and etravirine | Phase 2 | HIV-1 Infection | - | - |
MK8141 | Phase 2 | Hypertension | - | - |
Elbasvir Oral Granules | Phase 2 | HCV Infection | - | - |
MK0822A | Phase 2 | Vitamin D Deficiency | - | - |
MK0633 | Phase 2 | Atherosclerosis | - | - |
ATRIPLA^TM | Phase 2 | HIV-1 | - | - |
NC318 | Phase 2 | Advanced Non-small Cell Lung Cancer | - | - |
TATE and pembrolizumab | Phase 2 | Colorectal Cancer; Lung Cancer | - | - |
MK-2010 | Phase 2 | Advanced Solid Tumors | - | - |
Interferon-beta-1a, 66 microgram | Phase 2 | Ulcerative Colitis | - | - |
Histamine H1 Receptor Antagonist | Phase 2 | Advanced Solid Tumors | - | - |
MK-3475 (pembrolizumab) | Phase 2 | Ovarian Squamous Cell Carcinoma | - | - |
Histamine H2 Receptor Antagonist | Phase 2 | Advanced Solid Tumors | - | - |
Grazoprevir Oral Granules | Phase 2 | HCV Infection | - | - |
Doravirine, Tenofovir, Lamivudine - Open-Label | Phase 2 | HIV-1 | - | - |
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate -300 MG-300 MG | Phase 2 | Hiv | - | - |
suberoylanilide hydroxamic acid (SAHA, Vorinostat) | Phase 2 | Breast Cancer | - | - |
tamoxifen citrate (Tamoxifen) | Phase 2 | Breast Cancer | - | - |
MK633 | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Doxorubicin hydrochloride | Phase 2 | Breast Neoplasms | - | - |
INCB024360 | Phase 2 | Microsatellite-instability (MSI) High Colorectal Cancer (CRC) | - | - |
r-FSH | Phase 2 | Ovarian Stimulation | - | - |
Enclitide Chloride | Phase 2 | Hypercholesterolemia | - | - |
Pimicotinib | Phase 2 | Tenosynovial Giant Cell Tumor | - | - |
Pembrolizumab/Olaparib | Phase 2 | SCLC,Extensive Stage | - | - |
Neoadjuvant Treatment - mFOLFOX6 & Pembrolizumab | Phase 2 | Gastro Esophageal Junction Cancer | - | - |
Pembrolizumab Injection | Phase 2 | Squamous Cell Carcinoma | - | - |
Interleukin-2 | Phase 2 | Kidney Cancer | - | - |
coformulation pembrolizumab/quavonlimab | Phase 2 | Small Cell Lung Carcinoma | - | - |
ATRA | Phase 2 | Melanoma | - | - |
MK-2214 | Phase 2 | Early Alzheimer's Disease | - | - |
Pembrolizumab & ADG106 (Phase Ib) | Phase 2 | Advanced Solid Tumor | - | - |
OBP-301 | Phase 2 | Esophageal Adenocarcinoma | - | - |
Phase Ia dose-escalation part of FB849 Monotherapy | Phase 2 | Advanced Solid Tumor | - | - |
Dabrafenib | Phase 2 | Melanoma | - | - |
MK0524A, niacin (+) laropiprant | Phase 2 | Flushing | - | - |
ridaforolimus (MK8669) | Phase 2 | Prostate Cancer | - | - |
MK0683, vorinostat, Suberoylanilide Hydroxamic Acid (SAHA) | Phase 2 | B-cell Lymphoma | - | - |
Rolapitant Dose 1 | Phase 2 | Postoperative Nausea and Vomiting | - | - |
MK0359 | Phase 2 | Pulmonary Disease, Chronic Obstructive | - | - |
MK0524 | Phase 2 | Seasonal Allergies | - | - |
peginterferon alfa 2b | Phase 2 | Hepatitis C, Chronic | - | - |
MK-7262 | Phase 2 | Lipoprotein(a) | - | - |
DF9001 | Phase 2 | Solid Tumor, Adult | - | - |
Sargramostim | Phase 2 | Biliary Cancer | - | - |
Taxol | Phase 2 | Esophageal Adenocarcinoma | - | - |
TS-1 | Phase 2 | Gastric Cancer | - | - |
Rescue | Phase 2 | Type II Diabetes Mellitus | - | - |
AMG820 and pembrolizumab | Phase 2 | Pancreatic Cancer | - | - |
Recombinant human follicle stimulating hormone (r-hFSH) | Phase 2 | Infertility | - | - |
Regorafenib (Stivarga, BAY73-4506) | Phase 2 | Hepatocellular Carcinoma | - | - |
IRX 2 | Phase 2 | Breast Cancer | - | - |
Itraconazole | Phase 2 | Chronic Hepatitis C | - | - |
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (V501) | Phase 2 | HPV Infections | - | - |
Pegylated Interferon (peg-IFN) | Phase 2 | Hepatitis C | - | - |
Vorinostat and Etoposide | Phase 2 | Solid Tumors | - | - |
Ifinatamab Deruxtecan (I-DXd) | Phase 2 | Small Cell Lung Cancer | - | - |
Ruzasvir | Phase 2 | Hepatitis C | - | - |
Letermovir oral granules | Phase 2 | Cytomegalovirus (CMV) Infection | - | - |
Raltegravir Film-coated Tablet | Phase 2 | HIV Infection | - | - |
teicoplanin | Phase 2 | Osteomyelitis | - | - |
SCH 900271 | Phase 2 | Primary Hypercholesterolemia | - | - |
SCH 900518 | Phase 2 | Hepatitis C, Chronic | - | - |
MK5757 | Phase 2 | Schizophrenia | - | - |
Samatasvir | Phase 2 | Chronic Hepatitis C Virus | - | - |
Ulevostinag | Phase 2 | Head and Neck Squamous Cell Carcinoma (HNSCC) | - | - |
ARQ 501 in combination with gemcitabine | Phase 2 | Pancreatic Cancer | - | - |
V205C, measles, mumps, and rubella virus vaccine live | Phase 2 | Measles | - | - |
medroxyprogesterone acetate tablets OR megestrol acetate | Phase 2 | Endometrial Cancer | - | - |
Islatravir | Phase 2 | HIV-1 Infection | - | - |
RSV A Memphis 37b | Phase 2 | Respiratory Syncytial Virus | - | - |
SCH 619734 | Phase 2 | Cough | - | - |
ADL5747 | Phase 2 | Osteoarthritis of the Knee | - | - |
TR-701 | Phase 2 | Skin Diseases, Infectious | - | - |
MK3207 | Phase 2 | Migraine | - | - |
Grazoprevir (GZR) | Phase 2 | Hepatitis C Virus | - | - |
I-DXd | Phase 2 | Esophageal Squamous Cell Carcinoma | - | - |
SCH 56592 | Phase 2 | Onychomycosis | - | - |
Grazoprevir/Elbasvir FDC | Phase 2 | Hepatitis C | - | - |
MK-5442 | Phase 2 | Osteoporosis | - | - |
Caspofungin | Phase 2 | Candidiasis, Esophageal | - | - |
SCH 497079 | Phase 2 | Obesity | - | - |
tretinoin | Phase 2 | Acute Myeloid Leukemia | - | - |
MK-0482 | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
EBC | Phase 2 | Colorectal Cancer | - | - |
Guadecitabine | Phase 2 | Recurrent Fallopian Tube Carcinoma | - | - |
FLX475 (tivumecirnon) | Phase 2 | Advanced Cancer | - | - |
MK0736 | Phase 2 | Hypertension | - | - |
FLX475 | Phase 2 | Gastric Cancer | - | - |
Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 20/40/40/20 | Phase 2 | Papillomavirus Infections | - | - |
MK0686 | Phase 2 | Pain, Postoperative | - | - |
MK-6213 | Phase 2 | Hypercholesterolemia | - | - |
VigantOL oil plus interferon beta-1a (Rebif) | Phase 2 | Relapsing-Remitting Multiple Sclerosis | - | - |
Vicriviroc maleate | Phase 2 | HIV | - | - |
MK-8690 | Phase 2 | Colitis Ulcerative | - | - |
MK0429 | Phase 2 | Post-Menopausal Osteoporosis | - | - |
Letermovir Pill | Phase 2 | CMV | - | - |
Pyronaridine | Phase 2 | Malaria Infection | - | - |
MK-0634 | Phase 2 | Urinary Incontinence | - | - |
ridaforolimus + dalotuzumab | Phase 2 | Breast Cancer | - | - |
rolofyline | Phase 2 | Congestive Heart Failure | - | - |
Posaconazole IV | Phase 2 | Invasive Aspergillosis | - | - |
r-hFSH | Phase 2 | Infertility | - | - |
MK0639, indinavir sulfate | Phase 2 | HIV Infections | - | - |
PR51 (3, 10) | Phase 2 | Bacterial Infections; Virus Diseases | - | - |
carboplatin AUC of 6, paclitaxel, and pembrolizumab, i.v. on day 1 | Phase 2 | Squamous Cell Carcinoma of Larynx | - | - |
Methotrexate 1 GM Injection | Phase 2 | Gestational Trophoblastic Neoplasias (GTN) | - | - |
TEW-7197 | Phase 2 | Metastatic Colorectal Cancer | - | - |
M9140 | Phase 2 | Solid Tumors | - | - |
Imprime PGG | Phase 2 | Malignant Neoplasm of Breast | - | - |
Mirdametinib | Phase 2 | Central Nervous System Tumors | - | - |
Crinone | Phase 2 | Postmenopausal Endometrium | - | - |
Posaconazole PFS | Phase 2 | Invasive Fungal Infection | - | - |
Bintrafusp Alfa | Phase 2 | Nasopharyngeal Carcinoma | - | - |
Pembrolizumab (Keytruda) | Phase 2 | Thyroid Cancer | - | - |
Axatilimab | Phase 2 | TNBC - Triple-Negative Breast Cancer | - | - |
Alendronate | Phase 2 | Osteoporosis | - | - |
Nirogacestat | Phase 2 | Tumor | - | - |
D-1553 in combination with Drug: pembrolizumab, Drug:KEYTRUDA®, Drug: cetuximab, Drug: other | Phase 2 | Solid Tumor, Adult | - | - |
Adjuvant Treatment - mFOLFOX & Pembrolizumab | Phase 2 | Gastro Esophageal Junction Cancer | - | - |
MK-3475 (adjuvant) | Phase 2 | Cancer of Head and Neck | - | - |
mRNA-4157 | Phase 2 | Melanoma | - | - |
5-hydroxytryptamine 3 antagonist | Phase 2 | Chemotherapy-induced Nausea and Vomiting | - | - |
Boceprevir, Peg-interferon alfa 2b and Ribavirin | Phase 2 | HCV Coinfection | - | - |
Peg-Interferon α-2b or Peg-Interferon α-2a | Phase 2 | HCV Infection | - | - |
ATG-022 | Phase 2 | Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | - | - |
ART Intensification | Phase 2 | HIV-1 Infection | - | - |
Allogeneic cytomegalovirus-specific T cells | Phase 2 | Glioblastoma Multiforme | - | - |
RPL554 Suspension | Phase 2 | COPD | - | - |
pembrolizumab KEYTRUDA® | Phase 2 | Advanced Solid Tumor | - | - |
MK-4208 | Phase 2 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | - | - |
Carboplatin/Paclitaxel | Phase 2 | Urologic Neoplasms | - | - |
Bavituximab | Phase 2 | Hepatocellular Carcinoma | - | - |
Vorinostat, Lenalinomide and Dexamethasone | Phase 2 | Multiple Myeloma | - | - |
Talimogene Laherparepvec | Phase 2 | Hepatocellular Carcinoma | - | - |
STK-012 | Phase 2 | Advanced Solid Tumor | - | - |
CPA | Phase 2 | Relapsed Diffuse Large B-cell Lymphoma | - | - |
Imipenem/Cilastatin/Relebactam | Phase 2 | Hematopoietic and Lymphoid Cell Neoplasm | - | - |
Posaconazole tablet | Phase 2 | Invasive Aspergillosis | - | - |
ISA101b | Phase 2 | HPV-Related Squamous Cell Carcinoma | - | - |
ADV/HSV-tk | Phase 2 | Metastatic Non-small Cell Lung Cancer | - | - |
Testosterone Enanthate | Phase 2 | Male Hypogonadism | - | - |
BET Bromodomain Inhibitor ZEN-3694 | Phase 2 | Castration-Resistant Prostate Carcinoma | - | - |
olaparibp, embro | Phase 2 | Ovarian Cancer | - | - |
aprepitant, ondansetron, dexamethasone | Phase 2 | Nausea | - | - |
azacytidine | Phase 2 | Lymphoma | - | - |
galinpepimut-S | Phase 2 | Acute Myelogenous Leukemia | - | - |
Neoadjuvant Pembrolizumab | Phase 2 | Breast Cancer | - | - |
Entereg | Phase 2 | Laparoscopic Colonic Resection | - | - |
D-1553 | Phase 2 | Solid Tumor, Adult | - | - |
Bilastine | Phase 2 | Seasonal Allergic Rhinitis | - | - |
Q901 | Phase 2 | Advanced Cancer | - | - |
5HT3 | Phase 2 | Chemotherapy-Induced Nausea and Vomiting | - | - |
FOLFIRI + Cetuximab | Phase 2 | Metastatic Colorectal Cancer | - | - |
GVAX Pancreatic Cancer Vaccine | Phase 2 | Pancreatic Cancer | - | - |
Lenvatinib Mesylate | Phase 2 | Kidney Cancer | - | - |
Polatuzumab vedotin | Phase 2 | Lymphoma, Large B-Cell, Diffuse | - | - |
IMGN853 | Phase 2 | Endometrial Cancer | - | - |
GAd-209-FSP low dose | Phase 2 | Solid Tumor, Adult | - | - |
Peptide Receptor Radionuclide Therapy (PRRT) using 177Lu-DOTA0-Tyr3-Octreotate | Phase 2 | Metastatic Malignant Neoplasm in the Liver | - | - |
Vinblastine | Phase 2 | Classical Hodgkin Lymphoma | - | - |
Defactinib | Phase 2 | Resectable Pancreatic Ductal Adenocarcinoma (PDAC) | - | - |
ARX201 | Phase 2 | Growth Hormone Deficiency | - | - |
Background ART Regimen | Phase 2 | HIV Infections | - | - |
r-hLH | Phase 2 | Infertility | - | - |
Obinutuzumab/Intravenous | Phase 2 | Cancer | - | - |
V114 High Dose | Phase 2 | Pneumococcal Infections | - | - |
V114 High Dose with Alternative Carrier Protein | Phase 2 | Pneumococcal Infections | - | - |
ACE-536 | Phase 2 | Beta-Thalassemia | - | - |
Pembrolizuma | Phase 2 | Metastatic Breast Cancer | - | - |
Vorinostat Velcade Dexamethasone | Phase 2 | Multiple Myeloma | - | - |
Pembrolizumab with All-Trans Retinoic Acid | Phase 2 | Stage IV Melanoma | - | - |
Elpipodect | Phase 2 | Schizophrenia | - | - |
ABL103 | Phase 2 | Solid Tumors | - | - |
CXA-101/tazobactam and metronidazole | Phase 2 | Complicated Intra-abdominal Infection | - | - |
modifiedFOLFOX6 + Cetuximab | Phase 2 | Metastatic Colorectal Cancer | - | - |
pembrolizumab, gemcitabine and cisplatin | Phase 2 | Bladder Cancer | - | - |
R-CHOP Protocol | Phase 2 | B Cell Lymphoma | - | - |
Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 40/40/40/40 | Phase 2 | Papillomavirus Infections | - | - |
Pembrolizumab in | Phase 2 | Metastatic Breast Cancer | - | - |
IO102-103 | Phase 2 | Head and Neck Squamous Cell Carcinoma | - | - |
Autologous dendritic cells | Phase 2 | Follicular Lymphoma | - | - |
Raltegravir Chewable Tablet | Phase 2 | HIV Infection | - | - |
darunavir/ritonavir | Phase 2 | HIV Infections | - | - |
V114 Lot 2 | Phase 2 | Pneumococcal Infections | - | - |
M7824 | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
Other Anti-Retroviral Therapy | Phase 2 | HIV Infection | - | - |
MK-3475 (neoadjuvant) | Phase 2 | Cancer of Head and Neck | - | - |
Bemcentinib | Phase 2 | Lung Cancer Metastatic | - | - |
Ulonivirine | Phase 2 | HIV-1 Infection | - | - |
Optimized background regimen | Phase 2 | HIV Infections | - | - |
indacaterol maleate/mometasone furoate | Phase 2 | Asthma | - | - |
etravirine | Phase 2 | HIV Infections | - | - |
open-label ridaforolimus (MK8669) | Phase 2 | Prostate Cancer | - | - |
PegIntron (PEG) | Phase 2 | Chronic Hepatitis C | - | - |
Atovaquone-Proguanil | Phase 2 | Malaria Infection | - | - |
Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 80/80/40/80 | Phase 2 | Papillomavirus Infections | - | - |
Mocaciclib (Q901) | Phase 2 | Advanced Cancer | - | - |
V114 Medium Dose with Alternative Carrier Protein | Phase 2 | Pneumococcal Infections | - | - |
Poly-ICLC | Phase 2 | Metastatic Colon Cancer | - | - |
Pegylated Interferon alpha 2b | Phase 2 | HIV-1 Infection | - | - |
UFT | Phase 2 | Metastatic Colorectal Cancer | - | - |
Vinblastine Sulfate | Phase 2 | Stage II Bladder Cancer AJCC v8 | - | - |
DPX-Survivac | Phase 2 | Relapsed Diffuse Large B-cell Lymphoma | - | - |
Bacillus Calmette-Guérin (BCG) | Phase 2 | Bladder Cancer | - | - |
HIF-2alpha Inhibitor PT2385 | Phase 2 | Recurrent Glioblastoma | - | - |
pTVG-HP | Phase 2 | Castration-resistant Prostate Cancer | - | - |
emtricitabine/tenofovir disoproxil fumarate/raltegravir | Phase 2 | HIV-2 Infection | - | - |
L19TNF | Phase 2 | Melanoma Stage III | - | - |
GX-188E | Phase 2 | Cervical Cancer | - | - |
GSK2636771 | Phase 2 | Melanoma and Other Malignant Neoplasms of Skin | - | - |
Human Papillomavirus vaccine | Phase 2 | Cervical High Grade Squamous Intraepithelial Lesion | - | - |
Tinodasertib | Phase 2 | Metastatic Colorectal Cancer | - | - |
Aprepitant/Ramosetron/Dexamethasone | Phase 2 | Chemotherapy-Induced Nausea and Vomiting | - | - |
Zepatier | Phase 2 | End Stage Renal Disease | - | - |
Prednisone or prednisolone | Phase 2 | Metastatic Castration-resistant Prostate Cancer | - | - |
Sitagliptin + Metformin | Phase 2 | Pre-diabetes | - | - |
ACP-196 in combination with pembrolizumab | Phase 2 | Metastatic Urothelial Carcinoma | - | - |
Cefepime | Phase 2 | Other Infectious Diseases | - | - |
Azithromycin ophthalmic | Phase 2 | Blepharitis | - | - |
129Xe Hyperpolarized | Phase 2 | Pulmonary Hypertension | - | - |
L19IL2 | Phase 2 | Melanoma Stage III | - | - |
Pegzilarginase | Phase 2 | Small-cell Lung Cancer | - | - |
Spevatamig (PT886) | Phase 2 | Gastric or Gastroesophageal Junction Adenocarcinoma | - | - |
MK-1775 and carboplatin | Phase 2 | Epithelial Ovarian Cancer | - | - |
EIDD-2801 | Phase 2 | SARS-CoV 2 | - | - |
Pembrolizumab/Intravenous | Phase 2 | Metastatic Uveal Melanoma | - | - |
Gemox, Cetuximab | Phase 2 | Advanced Biliary Cancer | - | - |
Encorafenib Oral Capsule + Cetuximab | Phase 2 | Colorectal Cancer | - | - |
cetuximab, cisplatin, capecitabine | Phase 2 | Gastric Cancer | - | - |
Epclusa | Phase 2 | Lung Diseases | - | - |
acetominophen | Phase 2 | Migraine | - | - |
FLOT | Phase 2 | Esophagogastric Adenocarcinoma | - | - |
Afatinib | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
Hyperpolarized 13C-Pyruvate | Phase 2 | Neuroendocrine Tumors | - | - |
Cyklokapron(R) | Phase 2 | Bloodloss | - | - |
IMG-7289 | Phase 2 | Thrombocythemia, Essential | - | - |
cis/carboplatin and etoposide | Phase 2 | Small Cell Lung Cancer (SCLC) | - | - |
Leucovorin (LV) or levoleucovorin | Phase 2 | Colorectal Cancer | - | - |
Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV∆G-ZEBOV-GP) | Phase 2 | Ebola Virus Disease | - | - |
PR51 (6, 10) | Phase 2 | Bacterial Infections; Virus Diseases | - | - |
GX-I7 | Phase 2 | Triple Negative Breast Cancer | - | - |
PR51 (6, 15) | Phase 2 | Bacterial Infections; Virus Diseases | - | - |
L-377202 | Phase 2 | Hormone Refractory Prostate Cancer | - | - |
Pembrolizumab(KEYTRUDA®) | Phase 2 | Triple Negative Breast Cancer | - | - |
pembrolizumab (KEYTRUDA®) | Phase 2 | Advanced Solid Tumors | - | - |
MK-0646 | Phase 2 | Neuroendocrine Tumors | - | - |
Ibutamoren Mesylate (MK-0677) | Phase 2 | Fibromyalgia | - | - |
Pembrolizumab, Cetuximab | Phase 2 | HNSCC | - | - |
TILT-123 | Phase 2 | Platinum-refractory Ovarian Carcinoma | - | - |
KEYTRUDA® (pembrolizumab) | Phase 2 | Solid Tumor, Adult | - | - |
anti-IGF-1R recombinant monoclonal antibody MK-0646 | Phase 2 | Lung Cancer | - | - |
Pembrolizumab IV infusion Q3W, with daily oral Olaparib | Phase 2 | Relapsed Peripheral T-Cell Lymphoma | - | - |
Cisplatin/Carboplatin; 5FU | Phase 2 | Head and Neck Cancer | - | - |
Other Parkinson's Disease treatments | Phase 2 | Parkinson Disease | - | - |
Abraxane | Phase 2 | Non-small Cell Lung Cancer | - | - |
Cetuximab (Erbitux) | Phase 2 | Cancer | - | - |
FOLFOX-4+cetuximab | Phase 2 | Colorectal Cancer | - | - |
Capecitabine/5-FU | Phase 2 | Colorectal Cancer | - | - |
Arm B Pemetrexed, Cisplatin and MK-0646 | Phase 2 | Non Small Cell Lung Cancer | - | - |
quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine or nonavalent human papillomavirus vaccine (HPV 6, 11, 16, 18, 31, 33, 45, 52, 58) | Phase 2 | Cancer Survivor | - | - |
Nesuparib | Phase 2 | Endometrial Cancer | - | - |
Odetiglucan | Phase 2 | Colorectal Adenocarcinoma Metastatic in the Liver | - | - |
Emtricitabine (FTC)/Tenofovir Disoproxil (TDF) | Phase 2 | Primary Biliary Cholangitis | - | - |
pTVG-AR | Phase 2 | Castration-resistant Prostate Cancer | - | - |
V114 Non-adjuvanted | Phase 2 | Pneumococcal Infections | - | - |
rVSVΔG-ZEBOV-GP, V920 | Phase 2 | Ebola Virus Disease | - | - |
Ataluren + Pembrolizumab | Phase 2 | Colorectal Cancer | - | - |
cancer
4 drugs in this indication
Pneumococcal Infections
3 drugs in this indication
breast cancer
2 drugs in this indication
Non Small Cell Lung Cancer
2 drugs in this indication
Melanoma
2 drugs in this indication
Recurrent Mantle Cell Lymphoma
2 drugs in this indication
HPV vaccine
1 drug in this indication
muscle invasive bladder cancer
1 drug in this indication
Muscle-invasive bladder cancer (MIBC), neoadjuvant and adjuvant treatment
1 drug in this indication
Melanoma Stage IV
1 drug in this indication
dMMR endometrial cancer
1 drug in this indication
Ebola
1 drug in this indication
oncology
1 drug in this indication
first-line treatment (specific indication not stated)
1 drug in this indication
cholesterol
1 drug in this indication
to reduce LDL-C in adults with hypercholesterolemia
1 drug in this indication
dMMR advanced or recurrent endometrial cancer
1 drug in this indication
cardiovascular disease
1 drug in this indication
Hypercholesterolemia (high levels of bad cholesterol)
1 drug in this indication
resectable muscle-invasive bladder cancer (MIBC)
1 drug in this indication
Hepatitis C, Chronic
1 drug in this indication
Dyslipidemia
1 drug in this indication
hidradenitis suppurativa
1 drug in this indication
cholesterol-lowering
1 drug in this indication
PCSK9 inhibitor for LDL-C and Lp(a) lowering
1 drug in this indication
Hepatitis C
1 drug in this indication
PANCREAS
1 drug in this indication
HIV PrEP
1 drug in this indication
Small Cell Lung Cancer
1 drug in this indication
kidney cancer
1 drug in this indication
Diabetic Macular Edema (DME)
1 drug in this indication
advanced renal cell carcinoma
1 drug in this indication
diabetic macular edema
1 drug in this indication
eye disease
1 drug in this indication
Non-small Cell Lung Cancer, NSCLC
1 drug in this indication
stage two or three bowel cancer
1 drug in this indication
ovarian cancer
1 drug in this indication
Advanced Solid Tumor
1 drug in this indication
Muscle Relaxation
1 drug in this indication
Colorectal Cancer
1 drug in this indication
Cisplatin-eligible muscle-invasive bladder cancer (MIBC)
1 drug in this indication
Metastatic tumor mutational burden-high (TMB-H) solid tumors
1 drug in this indication
metastatic neuroendocrine prostate cancer (NEPC)
1 drug in this indication
melanoma (personalized cancer vaccine)
1 drug in this indication
Perioperative treatment of resectable muscle-invasive bladder cancer (MIBC) in adults, in combination with Padcev
1 drug in this indication
cancer (wide set of oncology indications)
1 drug in this indication
Malignant Neoplasms of Male Genital Organs
1 drug in this indication
In combination with paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
1 drug in this indication
MASH (metabolic dysfunction-associated steatohepatitis)
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in MERCK's drug pipeline?→
CatalystAlert tracks 953 drug candidates in MERCK's (MRK) pipeline across Phase 3, Phase 2, Approved. Its lead program is sac-TMT (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is MERCK's next FDA catalyst?→
MERCK's (MRK) next tracked catalyst is a PDUFA date expected Apr 22, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track MRK biotech catalysts?→
Add MRK to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MERCK's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
